{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:10:26Z","timestamp":1783703426459,"version":"3.55.0"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00702-024-02757-3","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T09:01:43Z","timestamp":1711789303000},"page":"525-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-5925","authenticated-orcid":false,"given":"Fahd Fran\u00e7ois","family":"Hilal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0353-2777","authenticated-orcid":false,"given":"Jerome","family":"Jeanblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0384-4344","authenticated-orcid":false,"given":"Chlo\u00e9","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-0918","authenticated-orcid":false,"given":"Mickael","family":"Naassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1427-9332","authenticated-orcid":false,"given":"Olivier","family":"Pierrefiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-9432","authenticated-orcid":false,"given":"Sami","family":"Ben Hamida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,30]]},"reference":[{"key":"2757_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/02698811221080165","volume":"36","author":"G Agin-Liebes","year":"2022","unstructured":"Agin-Liebes G, Zeifman R, Luoma JB et al (2022) Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. J Psychopharmacol 36:295\u2013308. https:\/\/doi.org\/10.1177\/02698811221080165","journal-title":"J Psychopharmacol"},{"key":"2757_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.brainres.2014.07.051","volume":"1583","author":"M Al Ameri","year":"2014","unstructured":"Al Ameri M, Al Mansouri S, Al Maamari A, Bahi A (2014) The histone deacetylase (HDAC) inhibitor valproic acid reduces ethanol consumption and ethanol-conditioned place preference in rats. Brain Res 1583:122\u2013131. https:\/\/doi.org\/10.1016\/j.brainres.2014.07.051","journal-title":"Brain Res"},{"key":"2757_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","volume":"42","author":"LR Aleksandrova","year":"2021","unstructured":"Aleksandrova LR, Phillips AG (2021) Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Trends Pharmacol Sci 42:929\u2013942. https:\/\/doi.org\/10.1016\/j.tips.2021.08.003","journal-title":"Trends Pharmacol Sci"},{"key":"2757_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2019.07.007","volume":"105","author":"LR Aleksandrova","year":"2019","unstructured":"Aleksandrova LR, Wang YT, Phillips AG (2019) Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response. Neurosci Biobehav Rev 105:1\u201323. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.07.007","journal-title":"Neurosci Biobehav Rev"},{"key":"2757_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/alcalc\/agn043","volume":"43","author":"ZN Aliyev","year":"2008","unstructured":"Aliyev ZN, Aliyev NA (2008) Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study. Alcohol Alcohol 43:456\u2013459. https:\/\/doi.org\/10.1093\/alcalc\/agn043","journal-title":"Alcohol Alcohol"},{"key":"2757_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113546","volume":"416","author":"CAF Almeida","year":"2022","unstructured":"Almeida CAF, Pereira-Junior AA, Rangel JG et al (2022) Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice. Behav Brain Res 416:113546. https:\/\/doi.org\/10.1016\/j.bbr.2021.113546","journal-title":"Behav Brain Res"},{"key":"2757_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3389\/fphar.2018.00994","volume":"9","author":"K Alper","year":"2018","unstructured":"Alper K, Dong B, Shah R et al (2018) LSD administered as a single dose reduces alcohol consumption in C57BL\/6J mice. Front Pharmacol 9:994. https:\/\/doi.org\/10.3389\/fphar.2018.00994","journal-title":"Front Pharmacol"},{"key":"2757_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1074633","author":"K Alper","year":"2023","unstructured":"Alper K, Cange J, Sah R et al (2023) Psilocybin sex-dependently reduces alcohol consumption in C57BL\/6J mice. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1074633","journal-title":"Front Pharmacol"},{"key":"2757_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.828055","volume":"15","author":"EM Anderson","year":"2022","unstructured":"Anderson EM, Taniguchi M (2022) Epigenetic effects of addictive drugs in the nucleus accumbens. Front Mol Neurosci 15:828055. https:\/\/doi.org\/10.3389\/fnmol.2022.828055","journal-title":"Front Mol Neurosci"},{"key":"2757_CR02","doi-asserted-by":"publisher","unstructured":"Anderson T, Petranker R, Christopher A et al (2019) Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduct J 16:43. https:\/\/doi.org\/10.1186\/s12954-019-0308-4","DOI":"10.1186\/s12954-019-0308-4"},{"key":"2757_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.alcohol.2021.09.004","volume":"97","author":"CE Ardinger","year":"2021","unstructured":"Ardinger CE, Winkler G, Lapish CC, Grahame NJ (2021) Effect of ketamine on binge drinking patterns in crossed high alcohol-preferring (cHAP) mice. Alcohol 97:31\u201339. https:\/\/doi.org\/10.1016\/j.alcohol.2021.09.004","journal-title":"Alcohol"},{"key":"2757_CR11","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/npp.2013.65","volume":"38","author":"DS Arora","year":"2013","unstructured":"Arora DS, Nimitvilai S, Teppen TL et al (2013) Hyposensitivity to gamma-aminobutyric acid in the ventral tegmental area during alcohol withdrawal: reversal by histone deacetylase inhibitors. Neuropsychopharmacology 38:1674\u20131684. https:\/\/doi.org\/10.1038\/npp.2013.65","journal-title":"Neuropsychopharmacology"},{"key":"2757_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/acer.13382","volume":"41","author":"J Auta","year":"2017","unstructured":"Auta J, Zhang H, Pandey SC, Guidotti A (2017) Chronic alcohol exposure differentially alters one-carbon metabolism in rat liver and brain. Alcohol Clin Exp Res 41:1105\u20131111. https:\/\/doi.org\/10.1111\/acer.13382","journal-title":"Alcohol Clin Exp Res"},{"key":"2757_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91\u201395. https:\/\/doi.org\/10.1038\/nature10130","journal-title":"Nature"},{"key":"2757_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/BPL-190089","volume":"6","author":"Y Avchalumov","year":"2020","unstructured":"Avchalumov Y, Mandyam CD (2020) Synaptic plasticity and its modulation by alcohol. Brain Plast 6:103\u2013111. https:\/\/doi.org\/10.3233\/BPL-190089","journal-title":"Brain Plast"},{"key":"2757_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.706017","volume":"12","author":"M Avram","year":"2021","unstructured":"Avram M, Rogg H, Korda A et al (2021) Bridging the gap? Altered thalamocortical connectivity in psychotic and psychedelic states. Front Psychiatry 12:706017. https:\/\/doi.org\/10.3389\/fpsyt.2021.706017","journal-title":"Front Psychiatry"},{"key":"2757_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/ijms20051109","volume":"20","author":"A Bagheri","year":"2019","unstructured":"Bagheri A, Habibzadeh P, Razavipour SF et al (2019) HDAC inhibitors induce BDNF expression and promote neurite outgrowth in human neural progenitor cells-derived neurons. Int J Mol Sci 20:1109. https:\/\/doi.org\/10.3390\/ijms20051109","journal-title":"Int J Mol Sci"},{"key":"2757_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00424-015-1780-7","volume":"468","author":"L Baki","year":"2016","unstructured":"Baki L, Fribourg M, Younkin J et al (2016) Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells. Pflugers Arch 468:775\u2013793. https:\/\/doi.org\/10.1007\/s00424-015-1780-7","journal-title":"Pflugers Arch"},{"key":"2757_CR18","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1523\/JNEUROSCI.4571-14.2015","volume":"35","author":"E Barbier","year":"2015","unstructured":"Barbier E, Tapocik JD, Juergens N et al (2015) DNA methylation in the medial prefrontal cortex regulates alcohol-induced behavior and plasticity. J Neurosci 35:6153\u20136164. https:\/\/doi.org\/10.1523\/JNEUROSCI.4571-14.2015","journal-title":"J Neurosci"},{"key":"2757_CR19","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/mp.2016.131","volume":"22","author":"E Barbier","year":"2017","unstructured":"Barbier E, Johnstone AL, Khomtchouk BB et al (2017) Dependence-induced increase of alcohol self-administration and compulsive drinking mediated by the histone methyltransferase PRDM2. Mol Psychiatry 22:1746\u20131758. https:\/\/doi.org\/10.1038\/mp.2016.131","journal-title":"Mol Psychiatry"},{"key":"2757_CR03","doi-asserted-by":"publisher","unstructured":"Barbosa PCR, Strassman RJ, da Silveira DX et al (2016) Psychological and neuropsychological assessment of regular hoasca users. Compr Psychiatry 71:95\u2013105. https:\/\/doi.org\/10.1016\/j.comppsych.2016.09.003","DOI":"10.1016\/j.comppsych.2016.09.003"},{"key":"2757_CR04","doi-asserted-by":"publisher","unstructured":"Barbosa PCR, T\u00f3foli LF, Bogenschutz MP et al (2018) Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca. Front Psychiatry 9:136. https:\/\/doi.org\/10.3389\/fpsyt.2018.00136","DOI":"10.3389\/fpsyt.2018.00136"},{"key":"2757_CR20","doi-asserted-by":"publisher","unstructured":"Barksdale BR, Doss MK, Fonzo GA, Nemeroff CB (2024) The mechanistic divide in psychedelic neuroscience: an unbridgeable gap? Neurotherapeutics. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00322","DOI":"10.1016\/j.neurot.2024.e00322"},{"key":"2757_CR05","doi-asserted-by":"publisher","unstructured":"Barrett SP, Archambault J, Engelberg MJ, Pihl RO (2000) Hallucinogenic drugs attenuate the subjective response to alcohol in humans. Hum Psychopharmacol 15:559\u2013565. https:\/\/doi.org\/10.1002\/1099-1077(200010)15:73.0.CO;2-J","DOI":"10.1002\/1099-1077(200010)15:73.0.CO;2-J"},{"key":"2757_CR231","doi-asserted-by":"publisher","unstructured":"Barrett SP, Darredeau C, Pihl RO (2006). Patterns of simultaneous polysubstance use in drug using university\nstudents. Human psychopharmacology, 21:255\u2013263. https:\/\/doi.org\/10.1002\/hup.766","DOI":"10.1002\/hup.766"},{"key":"2757_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.molcel.2015.12.025","volume":"61","author":"G Bartolomei","year":"2016","unstructured":"Bartolomei G, Leutert M, Manzo M et al (2016) Analysis of chromatin ADP-ribosylation at the genome-wide level and at specific loci by ADPr-ChAP. Mol Cell 61:474\u2013485. https:\/\/doi.org\/10.1016\/j.molcel.2015.12.025","journal-title":"Mol Cell"},{"key":"2757_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06384-w","author":"F Benvenuti","year":"2023","unstructured":"Benvenuti F, Colombo D, Soverchia L et al (2023) Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories. Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-023-06384-w","journal-title":"Psychopharmacology"},{"key":"2757_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ijnp\/pyy102","volume":"22","author":"TDM Berkel","year":"2019","unstructured":"Berkel TDM, Zhang H, Teppen T et al (2019) Essential role of histone methyltransferase G9a in rapid tolerance to the anxiolytic effects of ethanol. Int J Neuropsychopharmacol 22:292\u2013302. https:\/\/doi.org\/10.1093\/ijnp\/pyy102","journal-title":"Int J Neuropsychopharmacol"},{"key":"2757_CR06","doi-asserted-by":"publisher","unstructured":"Berlowitz I, Walt H, Ghasarian C et al (2019) Short-Term Treatment Effects of a Substance Use Disorder Therapy Involving Traditional Amazonian Medicine. J Psychoactive Drugs 51:323\u2013334. https:\/\/doi.org\/10.1080\/02791072.2019.160795","DOI":"10.1080\/02791072.2019.160795"},{"key":"2757_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/08977190410001723308","volume":"22","author":"DK Binder","year":"2004","unstructured":"Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Fact 22:123\u2013131. https:\/\/doi.org\/10.1080\/08977190410001723308","journal-title":"Growth Fact"},{"key":"2757_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105136","volume":"146","author":"IO Blokhin","year":"2020","unstructured":"Blokhin IO, Khorkova O, Saveanu RV, Wahlestedt C (2020) Molecular mechanisms of psychiatric diseases. Neurobiol Dis 146:105136. https:\/\/doi.org\/10.1016\/j.nbd.2020.105136","journal-title":"Neurobiol Dis"},{"key":"2757_CR07","doi-asserted-by":"publisher","unstructured":"Bogenschutz MP, Ross S (2018) Therapeutic Applications of Classic Hallucinogens. Curr Top Behav Neurosci 36:361\u2013391. https:\/\/doi.org\/10.1007\/7854_2016_464","DOI":"10.1007\/7854_2016_464"},{"key":"2757_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA et al (2015) Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 29:289\u2013299. https:\/\/doi.org\/10.1177\/0269881114565144","journal-title":"J Psychopharmacol"},{"key":"2757_CR08","doi-asserted-by":"publisher","unstructured":"Bogenschutz MP, Ross S, Bhatt S et al (2022) Percentage of Heavy Drinking Days Following Psilocybin Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 79:953\u2013962. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.2096","DOI":"10.1001\/jamapsychiatry.2022.2096"},{"key":"2757_CR27","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41386-018-0034-8","volume":"43","author":"JP Bohnsack","year":"2018","unstructured":"Bohnsack JP, Hughes BA, O\u2019Buckley TK et al (2018) Histone deacetylases mediate GABAA receptor expression, physiology, and behavioral maladaptations in rat models of alcohol dependence. Neuropsychopharmacology 43:1518\u20131529. https:\/\/doi.org\/10.1038\/s41386-018-0034-8","journal-title":"Neuropsychopharmacology"},{"key":"2757_CR09","doi-asserted-by":"publisher","unstructured":"Bowen WT, Soskin RA, Chotlos JW (1970) Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism: a follow-up study. J Nerv Ment Dis 150:111\u2013118. https:\/\/doi.org\/10.1097\/00005053-197002000-00003","DOI":"10.1097\/00005053-197002000-00003"},{"key":"2757_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fphar.2013.00161","volume":"4","author":"CA Browne","year":"2013","unstructured":"Browne CA, Lucki I (2013) Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol 4:161. https:\/\/doi.org\/10.3389\/fphar.2013.00161","journal-title":"Front Pharmacol"},{"key":"2757_CR010","doi-asserted-by":"publisher","unstructured":"Cakic V, Potkonyak J, Marshall A (2010) Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users. Drug Alcohol Depend 111:30\u201337. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.03.015","DOI":"10.1016\/j.drugalcdep.2010.03.015"},{"key":"2757_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","volume":"48","author":"AE Calder","year":"2023","unstructured":"Calder AE, Hasler G (2023) Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 48:104\u2013112. https:\/\/doi.org\/10.1038\/s41386-022-01389-z","journal-title":"Neuropsychopharmacology"},{"key":"2757_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13229","volume":"27","author":"J Calleja-Conde","year":"2022","unstructured":"Calleja-Conde J, Morales-Garc\u00eda JA, Echeverry-Alzate V et al (2022a) *U* Classic psychedelics and alcohol use disorders: a systematic review of human and animal studies. Addict Biol 27:e13229. https:\/\/doi.org\/10.1111\/adb.13229","journal-title":"Addict Biol"},{"key":"2757_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","volume":"589","author":"LP Cameron","year":"2021","unstructured":"Cameron LP, Tombari RJ, Lu J et al (2021) A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature 589:474\u2013479. https:\/\/doi.org\/10.1038\/s41586-020-3008-z","journal-title":"Nature"},{"key":"2757_CR32","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/ejn.15929","volume":"57","author":"C Cannarozzo","year":"2022","unstructured":"Cannarozzo C, Rubiolo A, Casarotto P, Castr\u00e9n E (2022) Ketamine and its metabolite 2R,6R-hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without changing perineuronal nets enwrapping parvalbumin interneurons. Eur J Neurosci 57:940\u2013950","journal-title":"Eur J Neurosci"},{"key":"2757_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.phrs.2016.10.023","volume":"114","author":"FF Caputi","year":"2016","unstructured":"Caputi FF, Palmisano M, Carboni L et al (2016) Opioid gene expression changes and post-translational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3,4-methylenedioxy-methamphetamine (MDMA) exposure. Pharmacol Res 114:209\u2013218. https:\/\/doi.org\/10.1016\/j.phrs.2016.10.023","journal-title":"Pharmacol Res"},{"key":"2757_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","volume":"142","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL (2018) The entropic brain\u2014revisited. Neuropharmacology 142:167\u2013178. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.03.010","journal-title":"Neuropharmacology"},{"key":"2757_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/pr.118.017160","volume":"71","author":"RL Carhart-Harris","year":"2019","unstructured":"Carhart-Harris RL, Friston KJ (2019) REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev 71:316\u2013344. https:\/\/doi.org\/10.1124\/pr.118.017160","journal-title":"Pharmacol Rev"},{"key":"2757_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","volume":"8","author":"RL Carhart-Harris","year":"2014","unstructured":"Carhart-Harris RL, Leech R, Hellyer PJ et al (2014) The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci 8:20. https:\/\/doi.org\/10.3389\/fnhum.2014.00020","journal-title":"Front Hum Neurosci"},{"key":"2757_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1369-1600.2010.00251.x","volume":"15","author":"S Carnicella","year":"2010","unstructured":"Carnicella S, He D-Y, Yowell QV et al (2010) Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration. Addict Biol 15:424\u2013433. https:\/\/doi.org\/10.1111\/j.1369-1600.2010.00251.x","journal-title":"Addict Biol"},{"key":"2757_CR38","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto PC, Girych M, Fred SM et al (2021) Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 184:1299-1313.e19. https:\/\/doi.org\/10.1016\/j.cell.2021.01.034","journal-title":"Cell"},{"key":"2757_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124796","volume":"10","author":"MR Castino","year":"2015","unstructured":"Castino MR, Cornish JL, Clemens KJ (2015) Inhibition of histone deacetylases facilitates extinction and attenuates reinstatement of nicotine self-administration in rats. PLoS ONE 10:e0124796. https:\/\/doi.org\/10.1371\/journal.pone.0124796","journal-title":"PLoS ONE"},{"key":"2757_CR40","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/mp.2017.61","volume":"22","author":"E Castr\u00e9n","year":"2017","unstructured":"Castr\u00e9n E, Antila H (2017) Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatry 22:1085\u20131095. https:\/\/doi.org\/10.1038\/mp.2017.61","journal-title":"Mol Psychiatry"},{"key":"2757_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2018.00561","volume":"9","author":"EG Cata-Preta","year":"2018","unstructured":"Cata-Preta EG, Serra YA, da Moreira-Junior EC et al (2018) Ayahuasca and its DMT- and \u03b2-carbolines\u2014containing ingredients block the expression of ethanol-induced conditioned place preference in mice: role of the treatment environment. Front Pharmacol 9:561. https:\/\/doi.org\/10.3389\/fphar.2018.00561","journal-title":"Front Pharmacol"},{"key":"2757_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.266","volume":"7","author":"R Cervera-Juanes","year":"2017","unstructured":"Cervera-Juanes R, Wilhelm LJ, Park B et al (2017) Alcohol-dose-dependent DNA methylation and expression in the nucleus accumbens identifies coordinated regulation of synaptic genes. Transl Psychiatry 7:e994. https:\/\/doi.org\/10.1038\/tp.2016.266","journal-title":"Transl Psychiatry"},{"key":"2757_CR011","doi-asserted-by":"publisher","unstructured":"Chandler AL, Hartmaan MA (1960) Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in Psychotherapy. AMA Archives of General Psychiatry 2:286\u2013299. https:\/\/doi.org\/10.1001\/archpsyc.1960.03590090042008","DOI":"10.1001\/archpsyc.1960.03590090042008"},{"key":"2757_CR230","unstructured":"Cheek FE, Osmond H et al. (1966). Observations Regarding the Use of LSD-25 in the Treatment of\nAlcoholism. Journal of Psychopharmacology, 1:56-74."},{"key":"2757_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.alcohol.2019.02.005","volume":"78","author":"W-Y Chen","year":"2019","unstructured":"Chen W-Y, Zhang H, Gatta E et al (2019) The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal. Alcohol 78:79\u201387. https:\/\/doi.org\/10.1016\/j.alcohol.2019.02.005","journal-title":"Alcohol"},{"key":"2757_CR012","doi-asserted-by":"crossref","unstructured":"Chwelos N, Blewett DB, Smith CM, Hoffer A (1959) Use of d-lysergic acid diethylamide in the treatment of alcoholism. Q J Stud Alcohol 20:577\u2013590","DOI":"10.15288\/qjsa.1959.20.577"},{"key":"2757_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13114","volume":"27","author":"SL Clark","year":"2022","unstructured":"Clark SL, Chan RF, Zhao M et al (2022) Dual methylation and hydroxymethylation study of alcohol use disorder. Addict Biol 27:e13114. https:\/\/doi.org\/10.1111\/adb.13114","journal-title":"Addict Biol"},{"key":"2757_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1051\/jbio\/2019015","volume":"213","author":"R Corne","year":"2019","unstructured":"Corne R, Mongeau R (2019) Neurotrophic mechanisms of psychedelic therapy. Biol Aujourdhui 213:121\u2013129. https:\/\/doi.org\/10.1051\/jbio\/2019015","journal-title":"Biol Aujourdhui"},{"key":"2757_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2019.02.003","volume":"149","author":"NA Crowley","year":"2019","unstructured":"Crowley NA, Magee SN, Feng M et al (2019) Ketamine normalizes binge drinking-induced defects in glutamatergic synaptic transmission and ethanol drinking behavior in female but not male mice. Neuropharmacology 149:35\u201344. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.02.003","journal-title":"Neuropharmacology"},{"key":"2757_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.16288\/j.yczz.19-261","volume":"42","author":"HZ Cui","year":"2020","unstructured":"Cui HZ, Sun MZ, Wang RZ et al (2020) DNA methylation in the medial prefrontal cortex regulates alcohol-related behavior in rats. Yi Chuan 42:112\u2013125. https:\/\/doi.org\/10.16288\/j.yczz.19-261","journal-title":"Yi Chuan"},{"key":"2757_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.drugalcdep.2013.12.019","volume":"136","author":"E Dakwar","year":"2014","unstructured":"Dakwar E, Anerella C, Hart CL et al (2014) Therapeutic infusions of ketamine: do the psychoactive effects matter? Drug Alcohol Depend 136:153\u2013157. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.12.019","journal-title":"Drug Alcohol Depend"},{"key":"2757_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1176\/appi.ajp.2019.19070684","volume":"177","author":"E Dakwar","year":"2020","unstructured":"Dakwar E, Levin F, Hart CL et al (2020) A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: a randomized midazolam-controlled pilot trial. Am J Psychiatry 177:125\u2013133. https:\/\/doi.org\/10.1176\/appi.ajp.2019.19070684","journal-title":"Am J Psychiatry"},{"key":"2757_CR50","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1038\/s41467-019-13162-w","volume":"10","author":"RK Das","year":"2019","unstructured":"Das RK, Gale G, Walsh K et al (2019) Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories. Nat Commun 10:5187. https:\/\/doi.org\/10.1038\/s41467-019-13162-w","journal-title":"Nat Commun"},{"key":"2757_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","volume":"15","author":"AK Davis","year":"2020","unstructured":"Davis AK, Barrett FS, Griffiths RR (2020) Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. J Contextual Behav Sci 15:39\u201345. https:\/\/doi.org\/10.1016\/j.jcbs.2019.11.004","journal-title":"J Contextual Behav Sci"},{"key":"2757_CR52","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","volume":"28","author":"RE Daws","year":"2022","unstructured":"Daws RE, Timmermann C, Giribaldi B et al (2022) Increased global integration in the brain after psilocybin therapy for depression. Nat Med 28:844\u2013851. https:\/\/doi.org\/10.1038\/s41591-022-01744-z","journal-title":"Nat Med"},{"key":"2757_CR013","doi-asserted-by":"publisher","unstructured":"Denson R, Sydiaha D (1970) A Controlled Study of LSD Treatment in Alcoholism and Neurosis. The British Journal of Psychiatry 116:443\u2013445. https:\/\/doi.org\/10.1192\/bjp.116.533.443","DOI":"10.1192\/bjp.116.533.443"},{"key":"2757_CR53","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","volume":"41","author":"D De Gregorio","year":"2021","unstructured":"De Gregorio D, Aguilar-Valles A, Preller KH et al (2021) Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine. J Neurosci 41:891\u2013900. https:\/\/doi.org\/10.1523\/JNEUROSCI.1659-20.2020","journal-title":"J Neurosci"},{"key":"2757_CR54","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41386-018-0143-4","volume":"44","author":"RM de la Fuente","year":"2019","unstructured":"de la Fuente RM, Ibi D, Cuddy T et al (2019) Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity. Neuropsychopharmacology 44:443\u2013454. https:\/\/doi.org\/10.1038\/s41386-018-0143-4","journal-title":"Neuropsychopharmacology"},{"key":"2757_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109836","volume":"37","author":"RM de la Fuente","year":"2021","unstructured":"de la Fuente RM, Zhu B, Guevara CA et al (2021) Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice. Cell Rep 37:109836. https:\/\/doi.org\/10.1016\/j.celrep.2021.109836","journal-title":"Cell Rep"},{"key":"2757_CR56","doi-asserted-by":"publisher","first-page":"724606","DOI":"10.3389\/fpsyt.2021.724606","volume":"12","author":"CMH de Vos","year":"2021","unstructured":"de Vos CMH, Mason NL, Kuypers KPC (2021) Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics. Front Psychiatry 12:724606","journal-title":"Front Psychiatry"},{"key":"2757_CR57","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1007\/s11033-020-06009-x","volume":"47","author":"AJ DiVito","year":"2020","unstructured":"DiVito AJ, Leger RF (2020) Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review. Mol Biol Rep 47:9791\u20139799. https:\/\/doi.org\/10.1007\/s11033-020-06009-x","journal-title":"Mol Biol Rep"},{"key":"2757_CR014","doi-asserted-by":"publisher","unstructured":"Doering-Silveira E, Grob CS, de Rios MD et al (2005) Report on psychoactive drug use among adolescents using ayahuasca within a religious context. J Psychoactive Drugs 37:141\u2013144. https:\/\/doi.org\/10.1080\/02791072.2005.10399794","DOI":"10.1080\/02791072.2005.10399794"},{"key":"2757_CR58","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/cells12060963","volume":"12","author":"K Domanegg","year":"2023","unstructured":"Domanegg K, Sommer WH, Meinhardt MW (2023) Psychedelic targeting of metabotropic glutamate receptor 2 and its implications for the treatment of alcoholism. Cells 12:963. https:\/\/doi.org\/10.3390\/cells12060963","journal-title":"Cells"},{"key":"2757_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2022_410","author":"E Domi","year":"2023","unstructured":"Domi E, Barchiesi R, Barbier E (2023) Epigenetic dysregulation in alcohol-associated behaviors: preclinical and clinical evidence. Curr Top Behav Neurosci. https:\/\/doi.org\/10.1007\/7854_2022_410","journal-title":"Curr Top Behav Neurosci"},{"key":"2757_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12760","volume":"25","author":"I Drissi","year":"2020","unstructured":"Drissi I, Deschamps C, Fouquet G et al (2020) Memory and plasticity impairment after binge drinking in adolescent rat hippocampus: GluN2A\/GluN2B NMDA receptor subunits imbalance through HDAC2. Addict Biol 25:e12760. https:\/\/doi.org\/10.1111\/adb.12760","journal-title":"Addict Biol"},{"key":"2757_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12855","volume":"26","author":"P-A Dugu\u00e9","year":"2021","unstructured":"Dugu\u00e9 P-A, Wilson R, Lehne B et al (2021) Alcohol consumption is associated with widespread changes in blood DNA methylation: analysis of cross-sectional and longitudinal data. Addict Biol 26:e12855. https:\/\/doi.org\/10.1111\/adb.12855","journal-title":"Addict Biol"},{"key":"2757_CR015","doi-asserted-by":"publisher","unstructured":"Dusen WV, Wilson W, Miners W, Hook H (1967) Treatment of Alcoholism with Lysergide. Q J Stud Alcohol 28:295\u2013304. https:\/\/doi.org\/10.15288\/qjsa.1967.28.295","DOI":"10.15288\/qjsa.1967.28.295"},{"key":"2757_CR62","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.euroneuro.2021.10.278","volume":"53","author":"L Elsil\u00e4","year":"2021","unstructured":"Elsil\u00e4 L, Harkki J, Enberg E et al (2021) P.0294 Lysergic acid diethylamide acutely reduces intermittent ethanol intake without observable effects on sucrose consumption of intracranial stimulation reward in mice. Eur Neuropsychopharmacol 53:212. https:\/\/doi.org\/10.1016\/j.euroneuro.2021.10.278","journal-title":"Eur Neuropsychopharmacol"},{"key":"2757_CR63","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11920-011-0252-9","volume":"14","author":"M-A Enoch","year":"2012","unstructured":"Enoch M-A (2012) The influence of gene-environment interactions on the development of alcoholism and drug dependence. Curr Psychiatry Rep 14:150\u2013158. https:\/\/doi.org\/10.1007\/s11920-011-0252-9","journal-title":"Curr Psychiatry Rep"},{"key":"2757_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11920-001-0012-3","volume":"3","author":"MA Enoch","year":"2001","unstructured":"Enoch MA, Goldman D (2001) The genetics of alcoholism and alcohol abuse. Curr Psychiatry Rep 3:144\u2013151. https:\/\/doi.org\/10.1007\/s11920-001-0012-3","journal-title":"Curr Psychiatry Rep"},{"key":"2757_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/alcalc\/agr005","volume":"46","author":"F Eyer","year":"2011","unstructured":"Eyer F, Schreckenberg M, Hecht D et al (2011) Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study. Alcohol Alcohol 46:177\u2013184. https:\/\/doi.org\/10.1093\/alcalc\/agr005","journal-title":"Alcohol Alcohol"},{"key":"2757_CR016","doi-asserted-by":"publisher","unstructured":"F\u00e1bregas JM, Gonz\u00e1lez D, Fondevila S et al (2010) Assessment of addiction severity among ritual users of ayahuasca. Drug Alcohol Depend 111:257\u2013261. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.03.024","DOI":"10.1016\/j.drugalcdep.2010.03.024"},{"key":"2757_CR66","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/acer.12465","volume":"38","author":"A Finegersh","year":"2014","unstructured":"Finegersh A, Homanics GE (2014) Acute ethanol alters multiple histone modifications at model gene promoters in the cerebral cortex. Alcohol Clin Exp Res 38:1865\u20131873. https:\/\/doi.org\/10.1111\/acer.12465","journal-title":"Alcohol Clin Exp Res"},{"key":"2757_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02235-4","author":"LT Flynn","year":"2023","unstructured":"Flynn LT, Gao W-J (2023) DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-023-02235-4","journal-title":"Mol Psychiatry"},{"key":"2757_CR017","doi-asserted-by":"publisher","unstructured":"Garcia-Romeu A, Davis AK, Erowid F et al (2019) Cessation and reduction in alcohol consumption and misuse after psychedelic use. J Psychopharmacol 33:1088\u20131101. https:\/\/doi.org\/10.1177\/0269881119845793","DOI":"10.1177\/0269881119845793"},{"key":"2757_CR68","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/00008877-199812000-00004","volume":"9","author":"LR Gardell","year":"1998","unstructured":"Gardell LR, Whalen CA, Chambers MD et al (1998) Valproate reduces intake of alcoholic beverage among rats. Behav Pharmacol 9:683\u2013689. https:\/\/doi.org\/10.1097\/00008877-199812000-00004","journal-title":"Behav Pharmacol"},{"key":"2757_CR69","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/ijnp\/pyx075","volume":"20","author":"E Gatta","year":"2017","unstructured":"Gatta E, Auta J, Gavin DP et al (2017) Emerging role of one-carbon metabolism and DNA methylation enrichment on \u03b4-containing GABAA receptor expression in the cerebellum of subjects with alcohol use disorders (AUD). Int J Neuropsychopharmacol 20:1013\u20131026. https:\/\/doi.org\/10.1093\/ijnp\/pyx075","journal-title":"Int J Neuropsychopharmacol"},{"key":"2757_CR70","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s41380-019-0449-6","volume":"26","author":"E Gatta","year":"2021","unstructured":"Gatta E, Grayson DR, Auta J et al (2021) Genome-wide methylation in alcohol use disorder subjects: implications for an epigenetic regulation of the cortico-limbic glucocorticoid receptors (NR3C1). Mol Psychiatry 26:1029\u20131041. https:\/\/doi.org\/10.1038\/s41380-019-0449-6","journal-title":"Mol Psychiatry"},{"key":"2757_CR71","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","volume":"392","author":"GBD Alcohol Collaborators","year":"2018","unstructured":"GBD Alcohol Collaborators (2018) Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 392:1015\u20131035. https:\/\/doi.org\/10.1016\/S0140-6736(18)31310-2","journal-title":"Lancet"},{"key":"2757_CR72","doi-asserted-by":"publisher","DOI":"10.4303\/jdar\/236069","volume":"8","author":"B Getachew","year":"2019","unstructured":"Getachew B, Tizabi Y (2019) Both ketamine and NBQX attenuate alcohol-withdrawal induced depression in male rats. J Drug Alcohol Res 8:236069. https:\/\/doi.org\/10.4303\/jdar\/236069","journal-title":"J Drug Alcohol Res"},{"key":"2757_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114865","volume":"285","author":"B Gianfratti","year":"2022","unstructured":"Gianfratti B, Tabach R, Sakalem ME et al (2022) Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity. J Ethnopharmacol 285:114865. https:\/\/doi.org\/10.1016\/j.jep.2021.114865","journal-title":"J Ethnopharmacol"},{"key":"2757_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119220","volume":"256","author":"M Girn","year":"2022","unstructured":"Girn M, Roseman L, Bernhardt B et al (2022) Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. Neuroimage 256:119220. https:\/\/doi.org\/10.1016\/j.neuroimage.2022.119220","journal-title":"Neuroimage"},{"key":"2757_CR75","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1749-6632.1998.tb08237.x","volume":"844","author":"SD Glick","year":"1998","unstructured":"Glick SD, Maisonneuve IM (1998) Mechanisms of antiaddictive actions of ibogainea. Ann N Y Acad Sci 844:214\u2013226. https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb08237.x","journal-title":"Ann N Y Acad Sci"},{"key":"2757_CR76","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2000.tb06677.x","volume":"909","author":"SD Glick","year":"2000","unstructured":"Glick SD, Maisonneuve IM (2000) Development of novel medications for drug addiction. The legacy of an African shrub. Ann N Y Acad Sci 909:88\u2013103. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06677.x","journal-title":"Ann N Y Acad Sci"},{"key":"2757_CR77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0014-2999(02)01284-0","volume":"438","author":"SD Glick","year":"2002","unstructured":"Glick SD, Maisonneuve IM, Kitchen BA, Fleck MW (2002) Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur J Pharmacol 438:99\u2013105. https:\/\/doi.org\/10.1016\/s0014-2999(02)01284-0","journal-title":"Eur J Pharmacol"},{"key":"2757_CR78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neubiorev.2017.02.024","volume":"77","author":"S Goodwani","year":"2017","unstructured":"Goodwani S, Saternos H, Alasmari F, Sari Y (2017) Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder. Neurosci Biobehav Rev 77:14\u201331. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.02.024","journal-title":"Neurosci Biobehav Rev"},{"key":"2757_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2022.05.008","volume":"183","author":"A Goto","year":"2022","unstructured":"Goto A (2022) Synaptic plasticity during systems memory consolidation. Neurosci Res 183:1\u20136. https:\/\/doi.org\/10.1016\/j.neures.2022.05.008","journal-title":"Neurosci Res"},{"key":"2757_CR80","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.biopsych.2012.04.006","volume":"72","author":"D Govorko","year":"2012","unstructured":"Govorko D, Bekdash RA, Zhang C, Sarkar DK (2012) Male germline transmits fetal alcohol adverse effect on hypothalamic proopiomelanocortin gene across generations. Biol Psychiatry 72:378\u2013388. https:\/\/doi.org\/10.1016\/j.biopsych.2012.04.006","journal-title":"Biol Psychiatry"},{"key":"2757_CR81","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1176\/appi.ajp.2021.21030277","volume":"179","author":"M Grabski","year":"2022","unstructured":"Grabski M, McAndrew A, Lawn W et al (2022) Adjunctive ketamine with relapse prevention-based psychological therapy in the treatment of alcohol use disorder. AJP 179:152\u2013162. https:\/\/doi.org\/10.1176\/appi.ajp.2021.21030277","journal-title":"AJP"},{"key":"2757_CR82","doi-asserted-by":"publisher","first-page":"8439","DOI":"10.1523\/JNEUROSCI.1121-22.2022","volume":"42","author":"SF Grieco","year":"2022","unstructured":"Grieco SF, Castr\u00e9n E, Knudsen GM et al (2022) Psychedelics and neural plasticity: therapeutic implications. J Neurosci 42:8439\u20138449. https:\/\/doi.org\/10.1523\/JNEUROSCI.1121-22.2022","journal-title":"J Neurosci"},{"key":"2757_CR83","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature07925","volume":"459","author":"J-S Guan","year":"2009","unstructured":"Guan J-S, Haggarty SJ, Giacometti E et al (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55\u201360. https:\/\/doi.org\/10.1038\/nature07925","journal-title":"Nature"},{"key":"2757_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019351","volume":"6","author":"W Guo","year":"2011","unstructured":"Guo W, Crossey EL, Zhang L et al (2011) Alcohol exposure decreases CREB binding protein expression and histone acetylation in the developing cerebellum. PLoS ONE 6:e19351. https:\/\/doi.org\/10.1371\/journal.pone.0019351","journal-title":"PLoS ONE"},{"key":"2757_CR85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","volume":"277","author":"AL Halberstadt","year":"2015","unstructured":"Halberstadt AL (2015) Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res 277:99\u2013120. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.016","journal-title":"Behav Brain Res"},{"key":"2757_CR86","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","volume":"61","author":"AL Halberstadt","year":"2011","unstructured":"Halberstadt AL, Geyer MA (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology 61:364\u2013381. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01.017","journal-title":"Neuropharmacology"},{"key":"2757_CR018","doi-asserted-by":"publisher","unstructured":"Hallock RM, Dean A, Knecht ZA et al (2013) A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Drug Alcohol Depend 130:245\u2013248. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.11.010","DOI":"10.1016\/j.drugalcdep.2012.11.010"},{"key":"2757_CR019","doi-asserted-by":"publisher","unstructured":"Hollister LE (1969) Clinical use of psychotherapeutic drugs: current status. Clin Pharmacol Ther 10:170\u2013198. https:\/\/doi.org\/10.1002\/cpt1969102170","DOI":"10.1002\/cpt1969102170"},{"key":"2757_CR87","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","volume":"64","author":"DS Hasin","year":"2007","unstructured":"Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the united states: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:830\u2013842. https:\/\/doi.org\/10.1001\/archpsyc.64.7.830","journal-title":"Arch Gen Psychiatry"},{"key":"2757_CR88","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1096\/fj.06-6394fje","volume":"20","author":"D-Y He","year":"2006","unstructured":"He D-Y, Ron D (2006) Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug, Ibogaine. FASEB J 20:2420\u20132422. https:\/\/doi.org\/10.1096\/fj.06-6394fje","journal-title":"FASEB J"},{"key":"2757_CR89","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1523\/JNEUROSCI.3959-04.2005","volume":"25","author":"D-Y He","year":"2005","unstructured":"He D-Y, McGough NNH, Ravindranathan A et al (2005) Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption. J Neurosci 25:619\u2013628. https:\/\/doi.org\/10.1523\/JNEUROSCI.3959-04.2005","journal-title":"J Neurosci"},{"key":"2757_CR90","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/psymed.2023.0009","volume":"1","author":"JA Heinsbroek","year":"2023","unstructured":"Heinsbroek JA, Giannotti G, Bonilla J et al (2023) Tabernanthalog reduces motivation for heroin and alcohol in a polydrug use model. Psychedel Med (new Rochelle) 1:111\u2013119. https:\/\/doi.org\/10.1089\/psymed.2023.0009","journal-title":"Psychedel Med (new Rochelle)"},{"key":"2757_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.739012","author":"GM Henriques","year":"2021","unstructured":"Henriques GM, Anjos-Santos A, Rodrigues IRS et al (2021) Ibogaine blocks cue- and drug-induced reinstatement of conditioned place preference to ethanol in male mice. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.739012","journal-title":"Front Pharmacol"},{"key":"2757_CR92","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1051\/jbio\/2023028","volume":"217","author":"F Hilal","year":"2023","unstructured":"Hilal F, Jeanblanc J, Naassila M (2023) Interest and mechanisms of action of ketamine in alcohol addiction\u2014a review of clinical and preclinical studies. Biol Aujourdhui 217:161\u2013182. https:\/\/doi.org\/10.1051\/jbio\/2023028","journal-title":"Biol Aujourdhui"},{"key":"2757_CR93","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0741-8329(89)90022-0","volume":"6","author":"M Hillbom","year":"1989","unstructured":"Hillbom M, Tokola R, Kuusela V et al (1989) Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol 6:223\u2013226. https:\/\/doi.org\/10.1016\/0741-8329(89)90022-0","journal-title":"Alcohol"},{"key":"2757_CR94","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","volume":"33","author":"CA Hoeffer","year":"2010","unstructured":"Hoeffer CA, Klann E (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33:67\u201375. https:\/\/doi.org\/10.1016\/j.tins.2009.11.003","journal-title":"Trends Neurosci"},{"key":"2757_CR95","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1038\/npp.2016.3","volume":"41","author":"KM Holleran","year":"2016","unstructured":"Holleran KM, Wilson HH, Fetterly TL et al (2016) Ketamine and MAG lipase inhibitor-dependent reversal of evolving depressive-like behavior during forced abstinence from alcohol drinking. Neuropsychopharmacology 41:2062\u20132071. https:\/\/doi.org\/10.1038\/npp.2016.3","journal-title":"Neuropsychopharmacology"},{"key":"2757_CR96","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1021\/acschemneuro.5b00033","volume":"6","author":"T Holloway","year":"2015","unstructured":"Holloway T, Gonz\u00e1lez-Maeso J (2015) Epigenetic mechanisms of serotonin signaling. ACS Chem Neurosci 6:1099\u20131109. https:\/\/doi.org\/10.1021\/acschemneuro.5b00033","journal-title":"ACS Chem Neurosci"},{"key":"2757_CR97","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/nn927","volume":"5","author":"HW Horch","year":"2002","unstructured":"Horch HW, Katz LC (2002) BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat Neurosci 5:1177\u20131184. https:\/\/doi.org\/10.1038\/nn927","journal-title":"Nat Neurosci"},{"key":"2757_CR98","doi-asserted-by":"publisher","first-page":"1221719","DOI":"10.3389\/fphar.2023.1221719","volume":"14","author":"MG Hornick","year":"2023","unstructured":"Hornick MG, Stefanski A (2023) Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder. Front Pharmacol 14:1221719. https:\/\/doi.org\/10.3389\/fphar.2023.1221719","journal-title":"Front Pharmacol"},{"key":"2757_CR99","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fphar.2018.00330","volume":"9","author":"A Inserra","year":"2018","unstructured":"Inserra A (2018) Hypothesis: the psychedelic ayahuasca heals traumatic memories via a sigma 1 receptor-mediated epigenetic-mnemonic process. Front Pharmacol 9:330. https:\/\/doi.org\/10.3389\/fphar.2018.00330","journal-title":"Front Pharmacol"},{"key":"2757_CR100","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tips.2014.05.004","volume":"35","author":"M Ivanov","year":"2014","unstructured":"Ivanov M, Barragan I, Ingelman-Sundberg M (2014) Epigenetic mechanisms of importance for drug treatment. Trends Pharmacol Sci 35:384\u2013396. https:\/\/doi.org\/10.1016\/j.tips.2014.05.004","journal-title":"Trends Pharmacol Sci"},{"key":"2757_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2023.957203","volume":"17","author":"J Jarczak","year":"2023","unstructured":"Jarczak J, Miszczak M, Radwanska K (2023) Is DNA methylation in the brain a mechanism of alcohol use disorder? Front Behav Neurosci 17:957203. https:\/\/doi.org\/10.3389\/fnbeh.2023.957203","journal-title":"Front Behav Neurosci"},{"key":"2757_CR102","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1038\/s41380-023-02274-x","volume":"28","author":"AM Jaster","year":"2023","unstructured":"Jaster AM, Gonz\u00e1lez-Maeso J (2023) Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics. Mol Psychiatry 28:3595\u20133612. https:\/\/doi.org\/10.1038\/s41380-023-02274-x","journal-title":"Mol Psychiatry"},{"key":"2757_CR103","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1523\/JNEUROSCI.2270-05.2005","volume":"25","author":"J Jaworski","year":"2005","unstructured":"Jaworski J, Spangler S, Seeburg DP et al (2005) Control of dendritic arborization by the phosphoinositide-3\u2019-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 25:11300\u201311312. https:\/\/doi.org\/10.1523\/JNEUROSCI.2270-05.2005","journal-title":"J Neurosci"},{"key":"2757_CR104","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1523\/JNEUROSCI.3786-05.2006","volume":"26","author":"J Jeanblanc","year":"2006","unstructured":"Jeanblanc J, He D-Y, McGough NNH et al (2006) The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption. J Neurosci 26:1457\u20131464. https:\/\/doi.org\/10.1523\/JNEUROSCI.3786-05.2006","journal-title":"J Neurosci"},{"key":"2757_CR105","doi-asserted-by":"publisher","first-page":"13494","DOI":"10.1523\/JNEUROSCI.2243-09.2009","volume":"29","author":"J Jeanblanc","year":"2009","unstructured":"Jeanblanc J, He D-Y, Carnicella S et al (2009) Endogenous BDNF in the dorsolateral striatum gates alcohol drinking. J Neurosci 29:13494\u201313502. https:\/\/doi.org\/10.1523\/JNEUROSCI.2243-09.2009","journal-title":"J Neurosci"},{"key":"2757_CR106","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ejn.12067","volume":"37","author":"J Jeanblanc","year":"2013","unstructured":"Jeanblanc J, Logrip ML, Janak PH, Ron D (2013) BDNF-mediated regulation of ethanol consumption requires the activation of the MAP kinase pathway and protein synthesis. Eur J Neurosci 37:607\u2013612. https:\/\/doi.org\/10.1111\/ejn.12067","journal-title":"Eur J Neurosci"},{"key":"2757_CR107","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/adb.12039","volume":"19","author":"J Jeanblanc","year":"2014","unstructured":"Jeanblanc J, Coune F, Botia B, Naassila M (2014) Brain-derived neurotrophic factor mediates the suppression of alcohol self-administration by memantine. Addict Biol 19:758\u2013769. https:\/\/doi.org\/10.1111\/adb.12039","journal-title":"Addict Biol"},{"key":"2757_CR108","doi-asserted-by":"publisher","first-page":"pyv029","DOI":"10.1093\/ijnp\/pyv029","volume":"18","author":"J Jeanblanc","year":"2015","unstructured":"Jeanblanc J, Lemoine S, Jeanblanc V et al (2015) The class I-specific HDAC inhibitor MS-275 decreases motivation to consume alcohol and relapse in heavy drinking rats. Int J Neuropsychopharmacol 18:pyv029. https:\/\/doi.org\/10.1093\/ijnp\/pyv029","journal-title":"Int J Neuropsychopharmacol"},{"key":"2757_CR109","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neubiorev.2018.05.002","volume":"106","author":"J Jeanblanc","year":"2019","unstructured":"Jeanblanc J, Rolland B, Gierski F et al (2019) Animal models of binge drinking, current challenges to improve face validity. Neurosci Biobehav Rev 106:112\u2013121. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.05.002","journal-title":"Neurosci Biobehav Rev"},{"key":"2757_CR110","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0269881120959644","volume":"35","author":"LA Jelen","year":"2021","unstructured":"Jelen LA, Young AH, Stone JM (2021) Ketamine: a tale of two enantiomers. J Psychopharmacol 35:109\u2013123. https:\/\/doi.org\/10.1177\/0269881120959644","journal-title":"J Psychopharmacol"},{"key":"2757_CR111","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/070674376300800305","volume":"8","author":"SE Jensen","year":"1963","unstructured":"Jensen SE, Ramsay R (1963) Treatment of chronic alcoholism with lysergic acid diethylamide. Can Psychiatr Assoc J 8:182\u2013188. https:\/\/doi.org\/10.1177\/070674376300800305","journal-title":"Can Psychiatr Assoc J"},{"key":"2757_CR020","doi-asserted-by":"publisher","unstructured":"Jensen SE (1962) A Treatment Program for Alcoholics in a Mental Hospital. Q J Stud Alcohol 23:315\u2013320.\nhttps:\/\/doi.org\/10.15288\/qjsa.1962.23.315","DOI":"10.15288\/qjsa.1962.23.315"},{"key":"2757_CR021","doi-asserted-by":"publisher","unstructured":"Johnson FG (1969) LSD in the Treatment of Alcoholism. AJP 126:481\u2013487. https:\/\/doi.org\/10.1176\/ajp.126.4.481","DOI":"10.1176\/ajp.126.4.481"},{"key":"2757_CR112","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.biopsych.2022.06.036","volume":"93","author":"J Jung","year":"2023","unstructured":"Jung J, McCartney DL, Wagner J et al (2023) Additive effects of stress and alcohol exposure on accelerated epigenetic aging in alcohol use disorder. Biol Psychiatry 93:331\u2013341. https:\/\/doi.org\/10.1016\/j.biopsych.2022.06.036","journal-title":"Biol Psychiatry"},{"key":"2757_CR022","doi-asserted-by":"publisher","unstructured":"Kolp E, Young S, Freidman H et al (2007) Ketamine-Enhanced Psychotherapy: Preliminary Clinical Observations on its Effects in Treating Death Anxiety. International Journal of Transpersonal Studies 26. https:\/\/doi.org\/10.24972\/ijts.2007.26.1.1","DOI":"10.24972\/ijts.2007.26.1.1"},{"key":"2757_CR113","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/13543784.2023.2273493","volume":"32","author":"Z Kozak","year":"2023","unstructured":"Kozak Z, Johnson MW, Aaronson ST (2023) Assessing potential of psilocybin for depressive disorders. Expert Opin Investig Drugs 32:887\u2013900. https:\/\/doi.org\/10.1080\/13543784.2023.2273493","journal-title":"Expert Opin Investig Drugs"},{"key":"2757_CR114","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/acer.15118","volume":"47","author":"HR Kranzler","year":"2023","unstructured":"Kranzler HR, Hartwell EE (2023) Medications for treating alcohol use disorder: a narrative review. Alcohol Clin Exp Res (hoboken) 47:1224\u20131237. https:\/\/doi.org\/10.1111\/acer.15118","journal-title":"Alcohol Clin Exp Res (hoboken)"},{"key":"2757_CR023","doi-asserted-by":"publisher","unstructured":"Krupitsky EM, Grinenko AY (1997) Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. J Psychoactive Drugs 29:165\u2013183. https:\/\/doi.org\/10.1080\/02791072.1997.10400185","DOI":"10.1080\/02791072.1997.10400185"},{"key":"2757_CR024","doi-asserted-by":"publisher","unstructured":"Krupitsky EM, Grineko AY, Berkaliev TN et al (1992) The combination of psychedelic and aversive approaches in alcoholism treatment: The Affective Contra-Attribution method. Alcoholism Treatment Quarterly 9:99\u2013105. https:\/\/doi.org\/10.1300\/J020V09N01_09","DOI":"10.1300\/J020V09N01_09"},{"key":"2757_CR115","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/nn.3181","volume":"15","author":"M Kurita","year":"2012","unstructured":"Kurita M, Holloway T, Garc\u00eda-Bea A et al (2012) HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci 15:1245\u20131254. https:\/\/doi.org\/10.1038\/nn.3181","journal-title":"Nat Neurosci"},{"key":"2757_CR026","doi-asserted-by":"publisher","unstructured":"Kurland AA, Unger S, Shaffer JW, Savage C (1967) Psychedelic therapy utilizing LSD in the treatment of the alcoholic patient: a preliminary report. Am J Psychiatry 123:1202\u20131209. https:\/\/doi.org\/10.1176\/ajp.123.10.1202","DOI":"10.1176\/ajp.123.10.1202"},{"key":"2757_CR025","doi-asserted-by":"publisher","unstructured":"Kurland A, Savage C, Pahnke WN et al (1971) LSD in the Treatment of Alcoholics. Pharmacopsychiatry 4:83 94. https:\/\/doi.org\/10.1055\/s-0028-1094301","DOI":"10.1055\/s-0028-1094301"},{"key":"2757_CR116","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s00213-016-4377-8","volume":"233","author":"KPC Kuypers","year":"2016","unstructured":"Kuypers KPC, Riba J, de la Fuente RM et al (2016) Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology 233:3395\u20133403. https:\/\/doi.org\/10.1007\/s00213-016-4377-8","journal-title":"Psychopharmacology"},{"key":"2757_CR117","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","volume":"25","author":"AC Kwan","year":"2022","unstructured":"Kwan AC, Olson DE, Preller KH, Roth BL (2022) The neural basis of psychedelic action. Nat Neurosci 25:1407\u20131419. https:\/\/doi.org\/10.1038\/s41593-022-01177-4","journal-title":"Nat Neurosci"},{"key":"2757_CR118","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/00048678009159381","volume":"14","author":"DG Lambie","year":"1980","unstructured":"Lambie DG, Johnson RH, Vijayasenan ME, Whiteside EA (1980) Sodium valproate in the treatment of the alcohol withdrawal syndrome. Aust N Z J Psychiatry 14:213\u2013215. https:\/\/doi.org\/10.3109\/00048678009159381","journal-title":"Aust N Z J Psychiatry"},{"key":"2757_CR027","doi-asserted-by":"publisher","unstructured":"Lawn W, Hallak JE, Crippa JA et al (2017) Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey. Sci Rep 7:15201. https:\/\/doi.org\/10.1038\/s41598-017-14700-6","DOI":"10.1038\/s41598-017-14700-6"},{"key":"2757_CR028","doi-asserted-by":"publisher","unstructured":"Lea T, Amada N, Jungaberle H et al (2020) Microdosing psychedelics: Motivations, subjective effects and harm reduction. Int J Drug Policy 75:102600. https:\/\/doi.org\/10.1016\/j.drugpo.2019.11.008","DOI":"10.1016\/j.drugpo.2019.11.008"},{"key":"2757_CR119","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/acer.12088","volume":"37","author":"R Legastelois","year":"2013","unstructured":"Legastelois R, Botia B, Naassila M (2013) Blockade of ethanol-induced behavioral sensitization by sodium butyrate: descriptive analysis of gene regulations in the striatum. Alcohol Clin Exp Res 37:1143\u20131153. https:\/\/doi.org\/10.1111\/acer.12088","journal-title":"Alcohol Clin Exp Res"},{"key":"2757_CR120","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1051\/jbio\/2017014","volume":"211","author":"R Legastelois","year":"2017","unstructured":"Legastelois R, Jeanblanc J, Vilpoux C et al (2017) Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target. Biol Aujourdhui 211:83\u201391. https:\/\/doi.org\/10.1051\/jbio\/2017014","journal-title":"Biol Aujourdhui"},{"key":"2757_CR121","doi-asserted-by":"crossref","unstructured":"Lewis CR, Tafur J, Spencer S et al (2023) Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD. Front Psychiatry 14","DOI":"10.3389\/fpsyt.2023.959590"},{"key":"2757_CR029","doi-asserted-by":"publisher","unstructured":"Licht CL, Christoffersen M, Okholm M et al (2012) Simultaneous polysubstance use among Danish 3,4- methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. Hum Psychopharmacol 27:352\u2013363. https:\/\/doi.org\/10.1002\/hup.2234","DOI":"10.1002\/hup.2234"},{"key":"2757_CR122","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1096\/fj.07-099135","volume":"22","author":"ML Logrip","year":"2008","unstructured":"Logrip ML, Janak PH, Ron D (2008) Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J 22:2393\u20132404. https:\/\/doi.org\/10.1096\/fj.07-099135","journal-title":"FASEB J"},{"key":"2757_CR123","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1300\/J069v21n02_05","volume":"21","author":"LP Longo","year":"2002","unstructured":"Longo LP, Campbell T, Hubatch S (2002) Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. J Addict Dis 21:55\u201364. https:\/\/doi.org\/10.1300\/J069v21n02_05","journal-title":"J Addict Dis"},{"key":"2757_CR124","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/7854_2017_478","volume":"36","author":"JF L\u00f3pez-Gim\u00e9nez","year":"2018","unstructured":"L\u00f3pez-Gim\u00e9nez JF, Gonz\u00e1lez-Maeso J (2018) Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways. Curr Top Behav Neurosci 36:45\u201373. https:\/\/doi.org\/10.1007\/7854_2017_478","journal-title":"Curr Top Behav Neurosci"},{"key":"2757_CR125","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/acer.12850","volume":"39","author":"JA L\u00f3pez-Moreno","year":"2015","unstructured":"L\u00f3pez-Moreno JA, Marcos M, Calleja-Conde J et al (2015) Histone deacetylase gene expression following binge alcohol consumption in rats and humans. Alcohol Clin Exp Res 39:1939\u20131950. https:\/\/doi.org\/10.1111\/acer.12850","journal-title":"Alcohol Clin Exp Res"},{"key":"2757_CR030","doi-asserted-by":"publisher","unstructured":"Ludwig A, Levine J, Stark L, Lazar R (1969) A clinical study of LSD treatment in alcoholism. Am J Psychiatry 126:59\u201369. https:\/\/doi.org\/10.1176\/ajp.126.1.59","DOI":"10.1176\/ajp.126.1.59"},{"key":"2757_CR126","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1345\/aph.1G243","volume":"40","author":"E Lum","year":"2006","unstructured":"Lum E, Gorman SK, Slavik RS (2006) Valproic acid management of acute alcohol withdrawal. Ann Pharmacother 40:441\u2013448. https:\/\/doi.org\/10.1345\/aph.1G243","journal-title":"Ann Pharmacother"},{"key":"2757_CR127","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP et al (2018) Psychedelics promote structural and functional neural plasticity. Cell Rep 23:3170\u20133182. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.022","journal-title":"Cell Rep"},{"key":"2757_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2021.152257","volume":"109","author":"R Maatoug","year":"2021","unstructured":"Maatoug R, Bihan K, Duriez P et al (2021) Non-invasive and invasive brain stimulation in alcohol use disorders: a critical review of selected human evidence and methodological considerations to guide future research. Compr Psychiatry 109:152257. https:\/\/doi.org\/10.1016\/j.comppsych.2021.152257","journal-title":"Compr Psychiatry"},{"key":"2757_CR031","doi-asserted-by":"crossref","unstructured":"Maclean JR, Macdonald DC, Byrne UP, Hubbard AM (1961) The use of LSD-25 in the treatment of alcoholism and other psychiatric problems. Q J Stud Alcohol 22:34\u201345","DOI":"10.15288\/qjsa.1961.22.034"},{"key":"2757_CR129","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/7854_2017_479","volume":"36","author":"DA Martin","year":"2018","unstructured":"Martin DA, Nichols CD (2018) The effects of hallucinogens on gene expression. Curr Top Behav Neurosci 36:137\u2013158. https:\/\/doi.org\/10.1007\/7854_2017_479","journal-title":"Curr Top Behav Neurosci"},{"key":"2757_CR130","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphar.2019.00193","volume":"10","author":"S Marton","year":"2019","unstructured":"Marton S, Gonz\u00e1lez B, Rodr\u00edguez-Bottero S et al (2019) Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits. Front Pharmacol 10:193. https:\/\/doi.org\/10.3389\/fphar.2019.00193","journal-title":"Front Pharmacol"},{"key":"2757_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106620","volume":"190","author":"DC Mash","year":"2023","unstructured":"Mash DC (2023) IUPHAR\u2014invited review\u2014ibogaine\u2014a legacy within the current renaissance of psychedelic therapy. Pharmacol Res 190:106620. https:\/\/doi.org\/10.1016\/j.phrs.2022.106620","journal-title":"Pharmacol Res"},{"key":"2757_CR132","doi-asserted-by":"publisher","first-page":"PL45","DOI":"10.1016\/0024-3205(95)00273-9","volume":"57","author":"DC Mash","year":"1995","unstructured":"Mash DC, Staley JK, Baumann MH et al (1995) Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci 57:PL45\u2013PL50. https:\/\/doi.org\/10.1016\/0024-3205(95)00273-9","journal-title":"Life Sci"},{"key":"2757_CR032","doi-asserted-by":"publisher","unstructured":"McAndrew A, Lawn W, Stevens T et al (2017) A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial. Trials 18:159. https:\/\/doi.org\/10.1186\/s13063-017-1895-6","DOI":"10.1186\/s13063-017-1895-6"},{"key":"2757_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108129","volume":"172","author":"MM McGinnis","year":"2020","unstructured":"McGinnis MM, Parrish BC, McCool BA (2020) Withdrawal from chronic ethanol exposure increases postsynaptic glutamate function of insular cortex projections to the rat basolateral amygdala. Neuropharmacology 172:108129. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108129","journal-title":"Neuropharmacology"},{"key":"2757_CR134","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fgene.2014.00154","volume":"5","author":"EA Mead","year":"2014","unstructured":"Mead EA, Sarkar DK (2014) Fetal alcohol spectrum disorders and their transmission through genetic and epigenetic mechanisms. Front Genet 5:154. https:\/\/doi.org\/10.3389\/fgene.2014.00154","journal-title":"Front Genet"},{"key":"2757_CR135","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s41386-020-0694-z","volume":"45","author":"MW Meinhardt","year":"2020","unstructured":"Meinhardt MW, G\u00fcng\u00f6r C, Skorodumov I et al (2020) Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse. Neuropsychopharmacology 45:1316\u20131322. https:\/\/doi.org\/10.1038\/s41386-020-0694-z","journal-title":"Neuropsychopharmacology"},{"key":"2757_CR136","doi-asserted-by":"publisher","first-page":"eabh2399","DOI":"10.1126\/sciadv.abh2399","volume":"7","author":"MW Meinhardt","year":"2021","unstructured":"Meinhardt MW, Pfarr S, Fouquet G et al (2021) Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Sci Adv 7:eabh2399. https:\/\/doi.org\/10.1126\/sciadv.abh2399","journal-title":"Sci Adv"},{"key":"2757_CR137","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00213-010-2137-8","volume":"213","author":"HY Meltzer","year":"2011","unstructured":"Meltzer HY, Horiguchi M, Massey BW (2011) The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology 213:289\u2013305. https:\/\/doi.org\/10.1007\/s00213-010-2137-8","journal-title":"Psychopharmacology"},{"key":"2757_CR138","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1016\/j.addicn.2022.100025","volume":"3","author":"FR Mendes","year":"2022","unstructured":"Mendes FR, dos Costa CS, Wiltenburg VD et al (2022) Classic and non-classic psychedelics for substance use disorder: a review of their historic, past and current research. Addict Neurosci 3:100025. https:\/\/doi.org\/10.1016\/j.addicn.2022.100025","journal-title":"Addict Neurosci"},{"key":"2757_CR139","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41586-019-1700-7","volume":"574","author":"P Mews","year":"2019","unstructured":"Mews P, Egervari G, Nativio R et al (2019) Alcohol metabolism contributes to brain histone acetylation. Nature 574:717\u2013721. https:\/\/doi.org\/10.1038\/s41586-019-1700-7","journal-title":"Nature"},{"key":"2757_CR140","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1037\/pha0000324","volume":"28","author":"CN Miller","year":"2020","unstructured":"Miller CN, Kamens HM (2020) Reduced expression of ethanol sensitization by \u03b13\u03b24 nicotinic acetylcholine receptors in DBA\/2J mice. Exp Clin Psychopharmacol 28:348\u2013354. https:\/\/doi.org\/10.1037\/pha0000324","journal-title":"Exp Clin Psychopharmacol"},{"key":"2757_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.alcohol.2018.11.006","volume":"79","author":"CN Miller","year":"2019","unstructured":"Miller CN, Ruggery C, Kamens HM (2019) The \u03b13\u03b24 nicotinic acetylcholine receptor antagonist 18-Methoxycoronaridine decreases binge-like ethanol consumption in adult C57BL\/6J mice. Alcohol 79:1\u20136. https:\/\/doi.org\/10.1016\/j.alcohol.2018.11.006","journal-title":"Alcohol"},{"key":"2757_CR142","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1300\/J069v14n02_07","volume":"14","author":"GY Minuk","year":"1995","unstructured":"Minuk GY, Rockman GE, German GB et al (1995) The use of sodium valproate in the treatment of alcoholism. J Addict Dis 14:67\u201374. https:\/\/doi.org\/10.1300\/J069v14n02_07","journal-title":"J Addict Dis"},{"key":"2757_CR143","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0269881112456611","volume":"27","author":"MC Mithoefer","year":"2013","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT et al (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27:28\u201339. https:\/\/doi.org\/10.1177\/0269881112456611","journal-title":"J Psychopharmacol"},{"key":"2757_CR144","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","volume":"26","author":"R Moliner","year":"2023","unstructured":"Moliner R, Girych M, Brunello CA et al (2023) Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat Neurosci 26:1032\u20131041. https:\/\/doi.org\/10.1038\/s41593-023-01316-5","journal-title":"Nat Neurosci"},{"key":"2757_CR033","doi-asserted-by":"publisher","unstructured":"Mollaahmetoglu OM, Keeler J, Ashbullby KJ et al (2021) \u201cThis Is Something That Changed My Life\u201d: A Qualitative Study of Patients\u2019 Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders. Front Psychiatry 12:695335. https:\/\/doi.org\/10.3389\/fpsyt.2021.695335","DOI":"10.3389\/fpsyt.2021.695335"},{"key":"2757_CR145","first-page":"495","volume":"34","author":"S Moonat","year":"2012","unstructured":"Moonat S, Pandey SC (2012) Stress, epigenetics, and alcoholism. Alcohol Res 34:495\u2013505","journal-title":"Alcohol Res"},{"key":"2757_CR146","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00018-009-0135-y","volume":"67","author":"S Moonat","year":"2010","unstructured":"Moonat S, Starkman BG, Sakharkar A, Pandey SC (2010) Neuroscience of alcoholism: molecular and cellular mechanisms. Cell Mol Life Sci 67:73\u201388. https:\/\/doi.org\/10.1007\/s00018-009-0135-y","journal-title":"Cell Mol Life Sci"},{"key":"2757_CR147","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.biopsych.2013.01.012","volume":"73","author":"S Moonat","year":"2013","unstructured":"Moonat S, Sakharkar AJ, Zhang H et al (2013) Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism. Biol Psychiatry 73:763\u2013773. https:\/\/doi.org\/10.1016\/j.biopsych.2013.01.012","journal-title":"Biol Psychiatry"},{"key":"2757_CR148","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/acps.12818","volume":"136","author":"F M\u00fcller","year":"2017","unstructured":"M\u00fcller F, Lenz C, Dolder P et al (2017) Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations. Acta Psychiatr Scand 136:648\u2013657. https:\/\/doi.org\/10.1111\/acps.12818","journal-title":"Acta Psychiatr Scand"},{"key":"2757_CR149","first-page":"803","volume-title":"Handbook of behavioral neuroscience","author":"CP M\u00fcller","year":"2020","unstructured":"M\u00fcller CP, Schumann G, Kornhuber J, Kalinichenko LS (2020) Chapter 41\u2014the role of serotonin in alcohol use and abuse. In: M\u00fcller CP, Cunningham KA (eds) Handbook of behavioral neuroscience. Elsevier, Oxford, pp 803\u2013827"},{"key":"2757_CR150","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1081\/ada-100100597","volume":"26","author":"H Myrick","year":"2000","unstructured":"Myrick H, Brady KT, Malcolm R (2000) Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse 26:155\u2013160. https:\/\/doi.org\/10.1081\/ada-100100597","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2757_CR151","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.nbd.2014.11.023","volume":"74","author":"PJ Narayan","year":"2015","unstructured":"Narayan PJ, Lill C, Faull R et al (2015) Increased acetyl and total histone levels in post-mortem Alzheimer\u2019s disease brain. Neurobiol Dis 74:281\u2013294. https:\/\/doi.org\/10.1016\/j.nbd.2014.11.023","journal-title":"Neurobiol Dis"},{"key":"2757_CR152","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","volume":"618","author":"R Nardou","year":"2023","unstructured":"Nardou R, Sawyer E, Song YJ et al (2023) Psychedelics reopen the social reward learning critical period. Nature 618:790\u2013798. https:\/\/doi.org\/10.1038\/s41586-023-06204-3","journal-title":"Nature"},{"key":"2757_CR153","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478","journal-title":"Pharmacol Rev"},{"key":"2757_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.750142","volume":"12","author":"K Niinep","year":"2021","unstructured":"Niinep K, Anier K, Etel\u00e4inen T et al (2021) Repeated ethanol exposure alters DNA methylation status and dynorphin\/kappa-opioid receptor expression in nucleus accumbens of alcohol-preferring AA rats. Front Genet 12:750142. https:\/\/doi.org\/10.3389\/fgene.2021.750142","journal-title":"Front Genet"},{"key":"2757_CR155","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/00952990.2017.1310218","volume":"44","author":"GE Noller","year":"2018","unstructured":"Noller GE, Frampton CM, Yazar-Klosinski B (2018) Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. Am J Drug Alcohol Abuse 44:37\u201346. https:\/\/doi.org\/10.1080\/00952990.2017.1310218","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2757_CR156","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.alcohol.2019.10.005","volume":"84","author":"LM Nolli","year":"2020","unstructured":"Nolli LM, de Oliveira DGR, Alves SS et al (2020) Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction. Alcohol 84:67\u201375. https:\/\/doi.org\/10.1016\/j.alcohol.2019.10.005","journal-title":"Alcohol"},{"key":"2757_CR157","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.physbeh.2015.01.032","volume":"142","author":"AJ Oliveira-Lima","year":"2015","unstructured":"Oliveira-Lima AJ, Santos R, Hollais AW et al (2015) Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice. Physiol Behav 142:28\u201336. https:\/\/doi.org\/10.1016\/j.physbeh.2015.01.032","journal-title":"Physiol Behav"},{"key":"2757_CR158","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","volume":"61","author":"DE Olson","year":"2022","unstructured":"Olson DE (2022) Biochemical mechanisms underlying psychedelic-induced neuroplasticity. Biochemistry 61:127\u2013136. https:\/\/doi.org\/10.1021\/acs.biochem.1c00812","journal-title":"Biochemistry"},{"key":"2757_CR035","unstructured":"O\u2019reilly PO, Reich G (1962) Lysergic acid and the alcoholic. Dis Nerv Syst 23:331\u2013334"},{"key":"2757_CR034","doi-asserted-by":"publisher","unstructured":"O\u2019Reilly PO, Funk A (1964) LSD in Chronic Alcoholism. Canadian Psychiatric Association Journal 9:258\u2013261. https:\/\/doi.org\/10.1177\/070674376400900311","DOI":"10.1177\/070674376400900311"},{"key":"2757_CR036","doi-asserted-by":"publisher","unstructured":"Pahnke WN, Kurland AA, Unger S et al (1970) The Experimental Use of Psychedelic (LSD) Psychotherapy. JAMA 212:1856\u20131863. https:\/\/doi.org\/10.1001\/jama.1970.03170240060010","DOI":"10.1001\/jama.1970.03170240060010"},{"key":"2757_CR159","doi-asserted-by":"publisher","first-page":"11081","DOI":"10.1038\/ncomms11081","volume":"7","author":"E Palomer","year":"2016","unstructured":"Palomer E, Carretero J, Benvegn\u00f9 S et al (2016) Neuronal activity controls Bdnf expression via polycomb de-repression and CREB\/CBP\/JMJD3 activation in mature neurons. Nat Commun 7:11081. https:\/\/doi.org\/10.1038\/ncomms11081","journal-title":"Nat Commun"},{"key":"2757_CR160","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.molcel.2008.08.022","volume":"32","author":"RR Pandey","year":"2008","unstructured":"Pandey RR, Mondal T, Mohammad F et al (2008) Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 32:232\u2013246. https:\/\/doi.org\/10.1016\/j.molcel.2008.08.022","journal-title":"Mol Cell"},{"key":"2757_CR161","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.nbd.2015.03.019","volume":"82","author":"SC Pandey","year":"2015","unstructured":"Pandey SC, Sakharkar AJ, Tang L, Zhang H (2015) Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood. Neurobiol Dis 82:607\u2013619. https:\/\/doi.org\/10.1016\/j.nbd.2015.03.019","journal-title":"Neurobiol Dis"},{"key":"2757_CR162","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuropharm.2017.02.002","volume":"122","author":"SC Pandey","year":"2017","unstructured":"Pandey SC, Kyzar EJ, Zhang H (2017) Epigenetic basis of the dark side of alcohol addiction. Neuropharmacology 122:74\u201384. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.002","journal-title":"Neuropharmacology"},{"key":"2757_CR163","first-page":"613","volume":"13","author":"B P\u00e9rez-Cadah\u00eda","year":"2010","unstructured":"P\u00e9rez-Cadah\u00eda B, Drobic B, Khan P et al (2010) Current understanding and importance of histone phosphorylation in regulating chromatin biology. Curr Opin Drug Discov Devel 13:613\u2013622","journal-title":"Curr Opin Drug Discov Devel"},{"key":"2757_CR037","doi-asserted-by":"publisher","unstructured":"Perkins D, Opaleye ES, Simonova H et al (2022) Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey. Drug Alcohol Rev 41:265 274. https:\/\/doi.org\/10.1111\/dar.13348","DOI":"10.1111\/dar.13348"},{"issue":"Suppl 1","key":"2757_CR164","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.jcp.0000248602.68607.81","volume":"26","author":"IL Petrakis","year":"2006","unstructured":"Petrakis IL (2006) A rational approach to the pharmacotherapy of alcohol dependence. J Clin Psychopharmacol 26(Suppl 1):S3-12. https:\/\/doi.org\/10.1097\/01.jcp.0000248602.68607.81","journal-title":"J Clin Psychopharmacol"},{"key":"2757_CR165","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11920-006-0040-0","volume":"8","author":"HM Pettinati","year":"2006","unstructured":"Pettinati HM, Rabinowitz AR (2006) Choosing the right medication for the treatment of alcoholism. Curr Psychiatry Rep 8:383\u2013388. https:\/\/doi.org\/10.1007\/s11920-006-0040-0","journal-title":"Curr Psychiatry Rep"},{"key":"2757_CR038","doi-asserted-by":"publisher","unstructured":"Pizon AF, Lynch MJ, Benedict NJ et al (2018) Adjunct Ketamine Use in the Management of Severe Ethanol Withdrawal. Crit Care Med 46:e768\u2013e771. https:\/\/doi.org\/10.1097\/CCM.0000000000003204","DOI":"10.1097\/CCM.0000000000003204"},{"key":"2757_CR166","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.euroneuro.2016.01.005","volume":"26","author":"T Pokorny","year":"2016","unstructured":"Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX (2016) Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A\/2A agonist ergotamine on psilocybin-induced psychedelic experience. Eur Neuropsychopharmacol 26:756\u2013766. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.01.005","journal-title":"Eur Neuropsychopharmacol"},{"key":"2757_CR167","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1523\/JNEUROSCI.3136-11.2012","volume":"32","author":"I Ponomarev","year":"2012","unstructured":"Ponomarev I, Wang S, Zhang L et al (2012) Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. J Neurosci 32:1884\u20131897. https:\/\/doi.org\/10.1523\/JNEUROSCI.3136-11.2012","journal-title":"J Neurosci"},{"key":"2757_CR168","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.alcohol.2017.01.016","volume":"60","author":"I Ponomarev","year":"2017","unstructured":"Ponomarev I, Stelly CE, Morikawa H et al (2017) Mechanistic insights into epigenetic modulation of ethanol consumption. Alcohol 60:95\u2013101. https:\/\/doi.org\/10.1016\/j.alcohol.2017.01.016","journal-title":"Alcohol"},{"key":"2757_CR169","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0091-3057(83)90269-1","volume":"18","author":"AD Potthoff","year":"1983","unstructured":"Potthoff AD, Ellison G, Nelson L (1983) Ethanol intake increases during continuous administration of amphetamine and nicotine, but not several other drugs. Pharmacol Biochem Behav 18:489\u2013493. https:\/\/doi.org\/10.1016\/0091-3057(83)90269-1","journal-title":"Pharmacol Biochem Behav"},{"key":"2757_CR170","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.35082","volume":"7","author":"KH Preller","year":"2018","unstructured":"Preller KH, Burt JB, Ji JL et al (2018a) Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. Elife 7:e35082. https:\/\/doi.org\/10.7554\/eLife.35082","journal-title":"Elife"},{"key":"2757_CR171","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1523\/JNEUROSCI.1939-17.2018","volume":"38","author":"KH Preller","year":"2018","unstructured":"Preller KH, Schilbach L, Pokorny T et al (2018b) Role of the 5-HT2A receptor in self- and other-initiated social interaction in lysergic acid diethylamide-induced states: a pharmacological fMRI study. J Neurosci 38:3603\u20133611. https:\/\/doi.org\/10.1523\/JNEUROSCI.1939-17.2018","journal-title":"J Neurosci"},{"key":"2757_CR172","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","volume":"88","author":"KH Preller","year":"2020","unstructured":"Preller KH, Duerler P, Burt JB et al (2020) Psilocybin induces time-dependent changes in global functional connectivity. Biol Psychiat 88:197\u2013207. https:\/\/doi.org\/10.1016\/j.biopsych.2019.12.027","journal-title":"Biol Psychiat"},{"key":"2757_CR173","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/npp.2011.228","volume":"37","author":"BB Quednow","year":"2012","unstructured":"Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012) Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology 37:630\u2013640. https:\/\/doi.org\/10.1038\/npp.2011.228","journal-title":"Neuropsychopharmacology"},{"key":"2757_CR174","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13041-020-00582-9","volume":"13","author":"R Rauti","year":"2020","unstructured":"Rauti R, Cellot G, D\u2019Andrea P et al (2020) BDNF impact on synaptic dynamics: extra or intracellular long-term release differently regulates cultured hippocampal synapses. Mol Brain 13:43. https:\/\/doi.org\/10.1186\/s13041-020-00582-9","journal-title":"Mol Brain"},{"key":"2757_CR175","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/00952990.2018.1528265","volume":"45","author":"LA Ray","year":"2019","unstructured":"Ray LA, Bujarski S, Grodin E et al (2019) State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. Am J Drug Alcohol Abuse 45:124\u2013140. https:\/\/doi.org\/10.1080\/00952990.2018.1528265","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2757_CR176","first-page":"1324","volume":"25","author":"JP Reoux","year":"2001","unstructured":"Reoux JP, Saxon AJ, Malte CA et al (2001) Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. Alcohol Clin Exp Res 25:1324\u20131329","journal-title":"Alcohol Clin Exp Res"},{"key":"2757_CR177","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0091-3057(95)00152-m","volume":"52","author":"AH Rezvani","year":"1995","unstructured":"Rezvani AH, Overstreet DH, Lee YW (1995) Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats. Pharmacol Biochem Behav 52:615\u2013620. https:\/\/doi.org\/10.1016\/0091-3057(95)00152-m","journal-title":"Pharmacol Biochem Behav"},{"key":"2757_CR178","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/s0091-3057(97)10003-x","volume":"58","author":"AH Rezvani","year":"1997","unstructured":"Rezvani AH, Overstreet DH, Yang Y et al (1997) Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats. Pharmacol Biochem Behav 58:615\u2013619. https:\/\/doi.org\/10.1016\/s0091-3057(97)10003-x","journal-title":"Pharmacol Biochem Behav"},{"key":"2757_CR179","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pbb.2016.10.010","volume":"150\u2013151","author":"AH Rezvani","year":"2016","unstructured":"Rezvani AH, Cauley MC, Slade S et al (2016) Acute oral 18-methoxycoronaridine (18-MC) decreases both alcohol intake and IV nicotine self-administration in rats. Pharmacol Biochem Behav 150\u2013151:153\u2013157. https:\/\/doi.org\/10.1016\/j.pbb.2016.10.010","journal-title":"Pharmacol Biochem Behav"},{"key":"2757_CR180","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","volume":"26","author":"A Rickli","year":"2016","unstructured":"Rickli A, Moning OD, Hoener MC, Liechti ME (2016) Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. Eur Neuropsychopharmacol 26:1327\u20131337. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.05.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"2757_CR181","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrn3111","volume":"12","author":"AJ Robison","year":"2011","unstructured":"Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623\u2013637. https:\/\/doi.org\/10.1038\/nrn3111","journal-title":"Nat Rev Neurosci"},{"key":"2757_CR182","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00406-023-01590-1","volume":"273","author":"JM Rocha","year":"2023","unstructured":"Rocha JM, Reis JAS, Bouso JC et al (2023) Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies. Eur Arch Psychiatry Clin Neurosci 273:1527\u20131542. https:\/\/doi.org\/10.1007\/s00406-023-01590-1","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2757_CR183","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.2174\/1381612827666210203142539","volume":"27","author":"FD Rodriguez","year":"2021","unstructured":"Rodriguez FD (2021) Targeting epigenetic mechanisms to treat alcohol use disorders (AUD). Curr Pharm Des 27:3252\u20133272. https:\/\/doi.org\/10.2174\/1381612827666210203142539","journal-title":"Curr Pharm Des"},{"key":"2757_CR184","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/add.12231","volume":"108","author":"M Roerecke","year":"2013","unstructured":"Roerecke M, Rehm J (2013) Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction 108:1562\u20131578. https:\/\/doi.org\/10.1111\/add.12231","journal-title":"Addiction"},{"key":"2757_CR185","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/157015911795017317","volume":"9","author":"P Romieu","year":"2011","unstructured":"Romieu P, Deschatrettes E, Host L et al (2011) The inhibition of histone deacetylases reduces the reinstatement of cocaine-seeking behavior in rats. Curr Neuropharmacol 9:21\u201325. https:\/\/doi.org\/10.2174\/157015911795017317","journal-title":"Curr Neuropharmacol"},{"key":"2757_CR232","doi-asserted-by":"publisher","unstructured":"Rothberg RL, Azhari N, Haug NA, Dakwar, E. (2021). Mystical-type experiences occasioned by ketamine\nmediate its impact on at-risk drinking: Results from a randomized, controlled trial. Journal of\npsychopharmacology, 35:150\u2013158. https:\/\/doi.org\/10.1177\/0269881120970879","DOI":"10.1177\/0269881120970879"},{"key":"2757_CR186","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/10550499808998350","volume":"7","author":"RN Rosenthal","year":"1998","unstructured":"Rosenthal RN, Perkel C, Singh P et al (1998) A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal. Am J Addict 7:189\u2013197. https:\/\/doi.org\/10.3109\/10550499808998350","journal-title":"Am J Addict"},{"key":"2757_CR187","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.bbagrm.2014.03.001","volume":"1839","author":"SB Rothbart","year":"2014","unstructured":"Rothbart SB, Strahl BD (2014) Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 1839:627\u2013643. https:\/\/doi.org\/10.1016\/j.bbagrm.2014.03.001","journal-title":"Biochim Biophys Acta"},{"key":"2757_CR188","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neulet.2017.12.055","volume":"666","author":"J Ruda-Kucerova","year":"2018","unstructured":"Ruda-Kucerova J, Babinska Z, Luptak M et al (2018) Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats. Neurosci Lett 666:175\u2013180. https:\/\/doi.org\/10.1016\/j.neulet.2017.12.055","journal-title":"Neurosci Lett"},{"key":"2757_CR189","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1369-1600.2011.00408.x","volume":"17","author":"AVL Rueda","year":"2012","unstructured":"Rueda AVL, Teixeira AMA, Yonamine M, Camarini R (2012) Environmental enrichment blocks ethanol-induced locomotor sensitization and decreases BDNF levels in the prefrontal cortex in mice. Addict Biol 17:736\u2013745. https:\/\/doi.org\/10.1111\/j.1369-1600.2011.00408.x","journal-title":"Addict Biol"},{"key":"2757_CR190","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.687615","volume":"12","author":"SGD Ruffell","year":"2021","unstructured":"Ruffell SGD, Netzband N, Tsang W et al (2021) Ceremonial Ayahuasca in Amazonian retreats-mental health and epigenetic outcomes from a six-month naturalistic study. Front Psychiatry 12:687615. https:\/\/doi.org\/10.3389\/fpsyt.2021.687615","journal-title":"Front Psychiatry"},{"key":"2757_CR191","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1176\/appi.ajp.2014.14030382","volume":"172","author":"B Ruggeri","year":"2015","unstructured":"Ruggeri B, Nymberg C, Vuoksimaa E et al (2015) Association of protein phosphatase PPM1G with alcohol use disorder and brain activity during behavioral control in a genome-wide methylation analysis. Am J Psychiatry 172:543\u2013552. https:\/\/doi.org\/10.1176\/appi.ajp.2014.14030382","journal-title":"Am J Psychiatry"},{"key":"2757_CR040","unstructured":"Rydzy\u0144ski Z, Gruszczy\u0144ski W (1978) Treatment of alcoholism with psychotomimetic drugs. A follow-up study. Act Nerv Super (Praha) 20:81\u201382"},{"key":"2757_CR039","unstructured":"Rydzy\u0144ski Z, Cwynar S, Grzelak L, Jagiello W (1968) Prelminary report on the experience with psychosomimetic drugs in the treatment of alcobolism. Act Nerv Super (Praha) 10:273"},{"key":"2757_CR192","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1530-0277.2011.01581.x","volume":"36","author":"AJ Sakharkar","year":"2012","unstructured":"Sakharkar AJ, Zhang H, Tang L et al (2012) Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin Exp Res 36:61\u201371. https:\/\/doi.org\/10.1111\/j.1530-0277.2011.01581.x","journal-title":"Alcohol Clin Exp Res"},{"key":"2757_CR193","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1017\/S1461145714000054","volume":"17","author":"AJ Sakharkar","year":"2014","unstructured":"Sakharkar AJ, Zhang H, Tang L et al (2014) Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. Int J Neuropsychopharmacol 17:1207\u20131220. https:\/\/doi.org\/10.1017\/S1461145714000054","journal-title":"Int J Neuropsychopharmacol"},{"key":"2757_CR194","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1007\/s00429-016-1196-y","volume":"221","author":"AJ Sakharkar","year":"2016","unstructured":"Sakharkar AJ, Vetreno RP, Zhang H et al (2016) A role for histone acetylation mechanisms in adolescent alcohol exposure-induced deficits in hippocampal brain-derived neurotrophic factor expression and neurogenesis markers in adulthood. Brain Struct Funct 221:4691\u20134703. https:\/\/doi.org\/10.1007\/s00429-016-1196-y","journal-title":"Brain Struct Funct"},{"key":"2757_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107679","volume":"157","author":"AJ Sakharkar","year":"2019","unstructured":"Sakharkar AJ, Kyzar EJ, Gavin DP et al (2019) Altered amygdala DNA methylation mechanisms after adolescent alcohol exposure contribute to adult anxiety and alcohol drinking. Neuropharmacology 157:107679. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107679","journal-title":"Neuropharmacology"},{"key":"2757_CR196","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/archpsyc.62.1.37","volume":"62","author":"IM Salloum","year":"2005","unstructured":"Salloum IM, Cornelius JR, Daley DC et al (2005) Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 62:37\u201345. https:\/\/doi.org\/10.1001\/archpsyc.62.1.37","journal-title":"Arch Gen Psychiatry"},{"key":"2757_CR197","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jpsychires.2021.02.020","volume":"137","author":"B Sanders","year":"2021","unstructured":"Sanders B, Brula AQ (2021) Intranasal esketamine: from origins to future implications in treatment-resistant depression. J Psychiatr Res 137:29\u201335. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.02.020","journal-title":"J Psychiatr Res"},{"key":"2757_CR198","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0140-6736(09)60009-X","volume":"373","author":"MA Schuckit","year":"2009","unstructured":"Schuckit MA (2009) Alcohol-use disorders. Lancet 373:492\u2013501. https:\/\/doi.org\/10.1016\/S0140-6736(09)60009-X","journal-title":"Lancet"},{"key":"2757_CR199","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00213-022-06104-w","volume":"239","author":"YA Serra","year":"2022","unstructured":"Serra YA, Barros-Santos T, Anjos-Santos A et al (2022) Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice. Psychopharmacology 239:1679\u20131687. https:\/\/doi.org\/10.1007\/s00213-022-06104-w","journal-title":"Psychopharmacology"},{"key":"2757_CR041","doi-asserted-by":"publisher","unstructured":"Shah P, McDowell M, Ebisu R et al (2018) Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation. J Med Toxicol 14:229\u2013236. https:\/\/doi.org\/10.1007\/s13181-018-0662-8","DOI":"10.1007\/s13181-018-0662-8"},{"key":"2757_CR200","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"L-X Shao","year":"2021","unstructured":"Shao L-X, Liao C, Gregg I et al (2021) Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 109:2535-2544.e4. https:\/\/doi.org\/10.1016\/j.neuron.2021.06.008","journal-title":"Neuron"},{"key":"2757_CR201","unstructured":"Silvestre de Ferron B (2015) Alcool et m\u00e9moire: implication de la sous-unit\u00e9 GluN2B et de KCC2 dans les perturbations de la plasticit\u00e9 synaptique bidirectionnelle dans l\u2019hippocampe apr\u00e8s exposition pr\u00e9coce \u00e0 l\u2019\u00e9thanol. These de doctorat, Amiens"},{"key":"2757_CR202","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/adb.12161","volume":"20","author":"E Simon-O\u2019Brien","year":"2015","unstructured":"Simon-O\u2019Brien E, Alaux-Cantin S, Warnault V et al (2015) The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals. Addict Biol 20:676\u2013689. https:\/\/doi.org\/10.1111\/adb.12161","journal-title":"Addict Biol"},{"key":"2757_CR203","doi-asserted-by":"crossref","unstructured":"Singleton SP, Luppi AI, Carhart-Harris RL et al (2021) LSD flattens the brain\u2019s energy landscape: evidence from receptor-informed network control theory. 2021.05.14.444193","DOI":"10.1101\/2021.05.14.444193"},{"key":"2757_CR042","doi-asserted-by":"publisher","unstructured":"Smart RG, Storm T, Baker EFW, Solursh L (1966) A Controlled Study of Lysergide in the Treatment of Alcoholism. I. The Effects on Drinking Behavior. Q J Stud Alcohol 27:469\u2013482. https:\/\/doi.org\/10.15288\/qjsa.1966.27.469","DOI":"10.15288\/qjsa.1966.27.469"},{"key":"2757_CR043","doi-asserted-by":"crossref","unstructured":"Smith CM (1958) A new adjunct to the treatment of alcoholism: the hallucinogenic drugs. Q J Stud Alcohol 19:406\u2013417","DOI":"10.15288\/qjsa.1958.19.406"},{"key":"2757_CR204","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/1099800412444785","volume":"15","author":"KE Stephens","year":"2013","unstructured":"Stephens KE, Miaskowski CA, Levine JD et al (2013) Epigenetic regulation and measurement of epigenetic changes. Biol Res Nurs 15:373\u2013381. https:\/\/doi.org\/10.1177\/1099800412444785","journal-title":"Biol Res Nurs"},{"key":"2757_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.183","volume":"5","author":"E Stragier","year":"2015","unstructured":"Stragier E, Martin V, Davenas E et al (2015) Brain plasticity and cognitive functions after ethanol consumption in C57BL\/6J mice. Transl Psychiatry 5:e696. https:\/\/doi.org\/10.1038\/tp.2015.183","journal-title":"Transl Psychiatry"},{"key":"2757_CR206","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41\u201345. https:\/\/doi.org\/10.1038\/47412","journal-title":"Nature"},{"key":"2757_CR207","doi-asserted-by":"publisher","first-page":"ENEURO.0221-19.","DOI":"10.1523\/ENEURO.0221-19.2019","volume":"6","author":"CE Strong","year":"2019","unstructured":"Strong CE, Wright KN, Kabbaj M (2019) Sex and individual differences in alcohol intake are associated with differences in ketamine self-administration behaviors and nucleus accumbens dendritic spine density. eNeuro 6:ENEURO.0221-19.2019. https:\/\/doi.org\/10.1523\/ENEURO.0221-19.2019","journal-title":"eNeuro"},{"key":"2757_CR208","doi-asserted-by":"publisher","first-page":"pyu028","DOI":"10.1093\/ijnp\/pyu028","volume":"18","author":"S Subbanna","year":"2014","unstructured":"Subbanna S, Nagre NN, Umapathy NS et al (2014) Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice. Int J Neuropsychopharmacol 18:pyu028. https:\/\/doi.org\/10.1093\/ijnp\/pyu028","journal-title":"Int J Neuropsychopharmacol"},{"key":"2757_CR209","first-page":"127","volume":"33","author":"EV Sullivan","year":"2010","unstructured":"Sullivan EV, Harris RA, Pfefferbaum A (2010) Alcohol\u2019s effects on brain and behavior. Alcohol Res Health 33:127\u2013143","journal-title":"Alcohol Res Health"},{"key":"2757_CR210","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF02245936","volume":"118","author":"PM Sweetnam","year":"1995","unstructured":"Sweetnam PM, Lancaster J, Snowman A et al (1995) Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine\u2019s putative anti-addictive activity. Psychopharmacology 118:369\u2013376. https:\/\/doi.org\/10.1007\/BF02245936","journal-title":"Psychopharmacology"},{"key":"2757_CR211","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s002130051053","volume":"145","author":"KK Szumlinski","year":"1999","unstructured":"Szumlinski KK, Maisonneuve IM, Glick SD (1999) Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats. Psychopharmacology 145:227\u2013233. https:\/\/doi.org\/10.1007\/s002130051053","journal-title":"Psychopharmacology"},{"key":"2757_CR212","doi-asserted-by":"publisher","first-page":"9760","DOI":"10.1523\/JNEUROSCI.1427-04.2004","volume":"24","author":"N Takei","year":"2004","unstructured":"Takei N, Inamura N, Kawamura M et al (2004) Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J Neurosci 24:9760\u20139769. https:\/\/doi.org\/10.1523\/JNEUROSCI.1427-04.2004","journal-title":"J Neurosci"},{"key":"2757_CR044","doi-asserted-by":"publisher","unstructured":"Thomas G, Lucas P, Capler NR et al (2013) Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev 6:30\u201342. https:\/\/doi.org\/10.2174\/15733998113099990003","DOI":"10.2174\/15733998113099990003"},{"key":"2757_CR045","doi-asserted-by":"publisher","unstructured":"Tomsovic M, Edwards RV (1970) Lysergide Treatment of Schizophrenic and Nonschizophrenic Alcoholics; A Controlled Evaluation. Q J Stud Alcohol 31:932\u2013949. https:\/\/doi.org\/10.15288\/qjsa.1970.31.932","DOI":"10.15288\/qjsa.1970.31.932"},{"key":"2757_CR213","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nrn2132","volume":"8","author":"N Tsankova","year":"2007","unstructured":"Tsankova N, Renthal W, Kumar A, Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355\u2013367. https:\/\/doi.org\/10.1038\/nrn2132","journal-title":"Nat Rev Neurosci"},{"key":"2757_CR214","doi-asserted-by":"publisher","first-page":"1134454","DOI":"10.3389\/fpsyt.2023.1134454","volume":"14","author":"PB van der Meer","year":"2023","unstructured":"van der Meer PB, Fuentes JJ, Kaptein AA et al (2023) Therapeutic effect of psilocybin in addiction: a systematic review. Front Psychiatry 14:1134454. https:\/\/doi.org\/10.3389\/fpsyt.2023.1134454","journal-title":"Front Psychiatry"},{"key":"2757_CR215","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.adf0435","volume":"379","author":"MV Vargas","year":"2023","unstructured":"Vargas MV, Dunlap LE, Dong C et al (2023) Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science 379:700\u2013706. https:\/\/doi.org\/10.1126\/science.adf0435","journal-title":"Science"},{"key":"2757_CR216","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13072-015-0031-7","volume":"8","author":"KJ Veazey","year":"2015","unstructured":"Veazey KJ, Parnell SE, Miranda RC, Golding MC (2015) Dose-dependent alcohol-induced alterations in chromatin structure persist beyond the window of exposure and correlate with fetal alcohol syndrome birth defects. Epigenet Chromat 8:39. https:\/\/doi.org\/10.1186\/s13072-015-0031-7","journal-title":"Epigenet Chromat"},{"key":"2757_CR217","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2017.03.028","volume":"122","author":"O Vranjkovic","year":"2017","unstructured":"Vranjkovic O, Pina M, Kash TL, Winder DG (2017) The bed nucleus of the stria terminalis in drug-associated behavior and affect: a circuit-based perspective. Neuropharmacology 122:100\u2013106. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.03.028","journal-title":"Neuropharmacology"},{"key":"2757_CR218","doi-asserted-by":"publisher","first-page":"19430","DOI":"10.1038\/srep19430","volume":"6","author":"F Wang","year":"2016","unstructured":"Wang F, Xu H, Zhao H et al (2016) DNA co-methylation modules in postmortem prefrontal cortex tissues of European Australians with alcohol use disorders. Sci Rep 6:19430. https:\/\/doi.org\/10.1038\/srep19430","journal-title":"Sci Rep"},{"key":"2757_CR219","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.4","volume":"3","author":"V Warnault","year":"2013","unstructured":"Warnault V, Darcq E, Levine A et al (2013) Chromatin remodeling\u2014a novel strategy to control excessive alcohol drinking. Transl Psychiatry 3:e231. https:\/\/doi.org\/10.1038\/tp.2013.4","journal-title":"Transl Psychiatry"},{"key":"2757_CR220","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.alcohol.2017.07.011","volume":"66","author":"KA Windisch","year":"2018","unstructured":"Windisch KA, Czachowski CL (2018) Effects of group II metabotropic glutamate receptor modulation on ethanol- and sucrose-seeking and consumption in the rat. Alcohol 66:77\u201385. https:\/\/doi.org\/10.1016\/j.alcohol.2017.07.011","journal-title":"Alcohol"},{"key":"2757_CR221","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax4043","author":"K Witkiewitz","year":"2019","unstructured":"Witkiewitz K, Litten RZ, Leggio L (2019) Advances in the science and treatment of alcohol use disorder. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aax4043","journal-title":"Sci Adv"},{"key":"2757_CR222","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/ijms25010241","volume":"25","author":"A Wojtas","year":"2023","unstructured":"Wojtas A, Go\u0142embiowska K (2023) Molecular and medical aspects of psychedelics. Int J Mol Sci 25:241. https:\/\/doi.org\/10.3390\/ijms25010241","journal-title":"Int J Mol Sci"},{"key":"2757_CR046","doi-asserted-by":"publisher","unstructured":"Wong A, Benedict NJ, Armahizer MJ, Kane-Gill SL (2015) Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome. Ann Pharmacother 49:14\u201319. https:\/\/doi.org\/10.1177\/1060028014555859","DOI":"10.1177\/1060028014555859"},{"key":"2757_CR223","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/acer.14168","volume":"43","author":"K Xu","year":"2019","unstructured":"Xu K, Montalvo-Ortiz JL, Zhang X et al (2019) Epigenome-wide DNA methylation association analysis identified novel loci in peripheral cells for alcohol consumption among european american male veterans. Alcohol Clin Exp Res 43:2111\u20132121. https:\/\/doi.org\/10.1111\/acer.14168","journal-title":"Alcohol Clin Exp Res"},{"key":"2757_CR224","doi-asserted-by":"publisher","first-page":"740996","DOI":"10.3389\/fphar.2021.740996","volume":"12","author":"S Xu","year":"2022","unstructured":"Xu S, Yao X, Li B et al (2022) Uncovering the underlying mechanisms of ketamine as a novel antidepressant. Front Pharmacol 12:740996","journal-title":"Front Pharmacol"},{"key":"2757_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105375","volume":"164","author":"M Yang","year":"2021","unstructured":"Yang M, Barrios J, Yan J et al (2021) Causal roles of stress kinase JNK2 in DNA methylation and binge alcohol withdrawal-evoked behavioral deficits. Pharmacol Res 164:105375. https:\/\/doi.org\/10.1016\/j.phrs.2020.105375","journal-title":"Pharmacol Res"},{"key":"2757_CR047","doi-asserted-by":"publisher","unstructured":"Yockey RA, King KA, Vidourek RA (2019) \u201cGo ask Alice, when she\u2019s 10-feet tall\u201d: Psychosocial correlates to lifetime LSD use among a national sample of US adults. Journal of Psychedelic Studies 3:308\u2013314. https:\/\/doi.org\/10.1556\/2054.2019.014","DOI":"10.1556\/2054.2019.014"},{"key":"2757_CR048","doi-asserted-by":"publisher","unstructured":"Yoon G, Petrakis IL, Krystal JH (2019) Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder. JAMA Psychiatry 76:337\u2013338. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3990","DOI":"10.1001\/jamapsychiatry.2018.3990"},{"key":"2757_CR226","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1017\/S1461145713001144","volume":"17","author":"C You","year":"2014","unstructured":"You C, Zhang H, Sakharkar AJ et al (2014) Reversal of deficits in dendritic spines, BDNF and Arc expression in the amygdala during alcohol dependence by HDAC inhibitor treatment. Int J Neuropsychopharmacol 17:313\u2013322. https:\/\/doi.org\/10.1017\/S1461145713001144","journal-title":"Int J Neuropsychopharmacol"},{"key":"2757_CR227","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1111\/acer.13870","volume":"42","author":"C You","year":"2018","unstructured":"You C, Vandegrift BJ, Zhang H et al (2018) Histone deacetylase inhibitor suberanilohydroxamic acid treatment reverses hyposensitivity to \u03b3-aminobutyric acid in the ventral tegmental area during ethanol withdrawal. Alcohol Clin Exp Res 42:2160\u20132171. https:\/\/doi.org\/10.1111\/acer.13870","journal-title":"Alcohol Clin Exp Res"},{"key":"2757_CR228","doi-asserted-by":"publisher","first-page":"10130","DOI":"10.3390\/ijms241210130","volume":"24","author":"Q Zheng","year":"2023","unstructured":"Zheng Q, Wang H, Yan A et al (2023) DNA methylation in alcohol use disorder. Int J Mol Sci 24:10130. https:\/\/doi.org\/10.3390\/ijms241210130","journal-title":"Int J Mol Sci"},{"issue":"Suppl 17","key":"2757_CR229","doi-asserted-by":"publisher","first-page":"79","DOI":"10.15288\/jsads.2014.s17.79","volume":"75","author":"LR Zindel","year":"2014","unstructured":"Zindel LR, Kranzler HR (2014) Pharmacotherapy of alcohol use disorders: seventy-five years of progress. J Stud Alcohol Drugs Suppl 75(Suppl 17):79\u201388","journal-title":"J Stud Alcohol Drugs Suppl"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-024-02757-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T08:08:55Z","timestamp":1714205335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-024-02757-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":279,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2757"],"URL":"https:\/\/doi.org\/10.1007\/s00702-024-02757-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"assertion":[{"value":"24 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}